New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M
Purpose of Review This review will discuss the role of several key players in glioma classification and biology, namely isocitrate dehydrogenase 1 and 2 (IDH1/2), alpha thalassemia/mental retardation syndrome X-linked (ATRX), B-Raf (BRAF), telomerase reverse transcriptase (TERT), and H3K27M. Recent...
Saved in:
Published in | Current Neurology and Neuroscience Reports Vol. 17; no. 2; p. 19 |
---|---|
Main Authors | , , , , |
Format | Journal Article Book Review |
Language | English |
Published |
New York
Springer US
01.02.2017
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Purpose of Review
This review will discuss the role of several key players in glioma classification and biology, namely isocitrate dehydrogenase 1 and 2 (IDH1/2), alpha thalassemia/mental retardation syndrome X-linked (ATRX), B-Raf (BRAF), telomerase reverse transcriptase (TERT), and H3K27M.
Recent Findings
IDH1/2 mutation delineates oligoden-droglioma, astrocytoma, and secondary glioblastoma (GBM) from primary GBM and lower-grade gliomas with biology similar to GBM. Additional mutations including TERT, 1p/19q, and ATRX further guide glioma classification and diagnosis, as well as pointing directions toward individualized treatments for these distinct molecular subtypes. ATRX and TERT mutations suggest the importance of telomere maintenance in gliomagenesis. BRAF alterations are key in certain low-grade gliomas and pediatric gliomas but rarely in high-grade gliomas in adults. Histone mutations (e.g., H3K27M) and their effect on chromatin modulation are novel mechanisms of cancer generation and uniquely seen in midline gliomas in children and young adults.
Summary
Over the past decade, a remarkable accumulation of knowledge from the genomic study of gliomas has led to reclassification of tumors, new understanding of oncogenic mechanisms, and novel treatment strategies. |
---|---|
AbstractList | PURPOSE OF REVIEWThis review will discuss the role of several key players in glioma classification and biology, namely isocitrate dehydrogenase 1 and 2 (IDH1/2), alpha thalassemia/mental retardation syndrome X-linked (ATRX), B-Raf (BRAF), telomerase reverse transcriptase (TERT), and H3K27M.RECENT FINDINGSIDH1/2 mutation delineates oligoden-droglioma, astrocytoma, and secondary glioblastoma (GBM) from primary GBM and lower-grade gliomas with biology similar to GBM. Additional mutations including TERT, 1p/19q, and ATRX further guide glioma classification and diagnosis, as well as pointing directions toward individualized treatments for these distinct molecular subtypes. ATRX and TERT mutations suggest the importance of telomere maintenance in gliomagenesis. BRAF alterations are key in certain low-grade gliomas and pediatric gliomas but rarely in high-grade gliomas in adults. Histone mutations (e.g., H3K27M) and their effect on chromatin modulation are novel mechanisms of cancer generation and uniquely seen in midline gliomas in children and young adults. Over the past decade, a remarkable accumulation of knowledge from the genomic study of gliomas has led to reclassification of tumors, new understanding of oncogenic mechanisms, and novel treatment strategies. Purpose of Review This review will discuss the role of several key players in glioma classification and biology, namely isocitrate dehydrogenase 1 and 2 (IDH1/2), alpha thalassemia/mental retardation syndrome X-linked (ATRX), B-Raf (BRAF), telomerase reverse transcriptase (TERT), and H3K27M. Recent Findings IDH1/2 mutation delineates oligoden-droglioma, astrocytoma, and secondary glioblastoma (GBM) from primary GBM and lower-grade gliomas with biology similar to GBM. Additional mutations including TERT, 1p/19q, and ATRX further guide glioma classification and diagnosis, as well as pointing directions toward individualized treatments for these distinct molecular subtypes. ATRX and TERT mutations suggest the importance of telomere maintenance in gliomagenesis. BRAF alterations are key in certain low-grade gliomas and pediatric gliomas but rarely in high-grade gliomas in adults. Histone mutations (e.g., H3K27M) and their effect on chromatin modulation are novel mechanisms of cancer generation and uniquely seen in midline gliomas in children and young adults. Summary Over the past decade, a remarkable accumulation of knowledge from the genomic study of gliomas has led to reclassification of tumors, new understanding of oncogenic mechanisms, and novel treatment strategies. This review will discuss the role of several key players in glioma classification and biology, namely isocitrate dehydrogenase 1 and 2 (IDH1/2), alpha thalassemia/mental retardation syndrome X-linked (ATRX), B-Raf (BRAF), telomerase reverse transcriptase (TERT), and H3K27M. IDH1/2 mutation delineates oligoden-droglioma, astrocytoma, and secondary glioblastoma (GBM) from primary GBM and lower-grade gliomas with biology similar to GBM. Additional mutations including TERT, 1p/19q, and ATRX further guide glioma classification and diagnosis, as well as pointing directions toward individualized treatments for these distinct molecular subtypes. ATRX and TERT mutations suggest the importance of telomere maintenance in gliomagenesis. BRAF alterations are key in certain low-grade gliomas and pediatric gliomas but rarely in high-grade gliomas in adults. Histone mutations (e.g., H3K27M) and their effect on chromatin modulation are novel mechanisms of cancer generation and uniquely seen in midline gliomas in children and young adults. Over the past decade, a remarkable accumulation of knowledge from the genomic study of gliomas has led to reclassification of tumors, new understanding of oncogenic mechanisms, and novel treatment strategies. Purpose of Review This review will discuss the role of several key players in glioma classification and biology, namely isocitrate dehydrogenase 1 and 2 (IDH1/2), alpha thalassemia/mental retardation syndrome X-linked (ATRX), B-Raf (BRAF), telomerase reverse transcriptase (TERT), and H3K27M. Recent Findings IDH1/2 mutation delineates oligoden-droglioma, astrocytoma, and secondary glioblastoma (GBM) from primary GBM and lower-grade gliomas with biology similar to GBM. Additional mutations including TERT, 1p/19q, and ATRX further guide glioma classification and diagnosis, as well as pointing directions toward individualized treatments for these distinct molecular subtypes. ATRX and TERT mutations suggest the importance of telomere maintenance in gliomagenesis. BRAF alterations are key in certain low-grade gliomas and pediatric gliomas but rarely in high-grade gliomas in adults. Histone mutations (e.g., H3K27M) and their effect on chromatin modulation are novel mechanisms of cancer generation and uniquely seen in midline gliomas in children and young adults. Summary Over the past decade, a remarkable accumulation of knowledge from the genomic study of gliomas has led to reclassification of tumors, new understanding of oncogenic mechanisms, and novel treatment strategies. |
ArticleNumber | 19 |
Author | Cohen, Adam L. Guan, Jian Colman, Howard Jensen, Randy L. Karsy, Michael |
Author_xml | – sequence: 1 givenname: Michael surname: Karsy fullname: Karsy, Michael organization: Department of Neurosurgery, Clinical Neurosciences Center, University of Utah – sequence: 2 givenname: Jian surname: Guan fullname: Guan, Jian organization: Department of Neurosurgery, Clinical Neurosciences Center, University of Utah – sequence: 3 givenname: Adam L. surname: Cohen fullname: Cohen, Adam L. organization: Huntsman Cancer Institute, University of Utah, Department of Internal Medicine, University of Utah – sequence: 4 givenname: Randy L. surname: Jensen fullname: Jensen, Randy L. organization: Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Huntsman Cancer Institute, University of Utah – sequence: 5 givenname: Howard surname: Colman fullname: Colman, Howard email: howard.colman@hci.utah.edu organization: Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Huntsman Cancer Institute, University of Utah, Department of Neurosurgery, The University of Utah |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28271343$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kF1LIzEUhsOiWHX9Ad4sAW-86LgnX01m77pV26LuQumCdyGTSZYp04mbdBD_valVWQSvciDP-57Dc4T2utA5hE4JXBAA-T0RUhIogMgCJKWF-IIOiWC8GNGS7W1nqgoOnA7QUUorAJpT5QEaUEUlYZwdoukv94jvQuts35qIJ6FLTe2i2TR5wj5EPG2bsDY_8PxyNsTj5eJ-iH8uxtdDvLxaLId4xvANlXdf0b43bXInr-8x-nN9tZzMitvf0_lkfFtYztSmcNZWylZUKJJPrLxgTHBHTWmJAOkFqJrwynolvIXa16by3kmuauOJdXXFjtH5rvchhn-9Sxu9bpJ1bWs6F_qkiZKCwwiYzOjZB3QV-tjl614oEKUAmimyo2wMKUXn9UNs1iY-aQJ6a1nvLOtsWW8ta5Ez316b-2rt6vfEm9YM0B2Q8lf318X_Vn_a-gy5voUe |
CitedBy_id | crossref_primary_10_3390_molecules26041169 crossref_primary_10_1002_cpt_942 crossref_primary_10_1016_S1470_2045_21_00578_7 crossref_primary_10_3390_ph14020107 crossref_primary_10_1007_s12031_021_01796_9 crossref_primary_10_1016_j_ijrobp_2022_05_036 crossref_primary_10_1007_s00234_021_02674_2 crossref_primary_10_1016_j_jocn_2017_05_004 crossref_primary_10_1016_j_phymed_2020_153434 crossref_primary_10_3390_cancers12030549 crossref_primary_10_1007_s10555_023_10105_2 crossref_primary_10_3892_ol_2018_9634 crossref_primary_10_1016_j_crad_2019_03_020 crossref_primary_10_3390_ijms25115992 crossref_primary_10_1016_j_csbj_2021_08_019 crossref_primary_10_1182_blood_2017_09_805382 crossref_primary_10_1016_j_wneu_2017_03_076 crossref_primary_10_1016_j_wneu_2019_08_068 crossref_primary_10_1158_0008_5472_CAN_17_1139 crossref_primary_10_1007_s40272_019_00369_z crossref_primary_10_1016_j_wneu_2019_06_218 crossref_primary_10_1155_2023_4190849 crossref_primary_10_1007_s00381_020_04803_3 crossref_primary_10_1007_s00234_024_03297_z crossref_primary_10_1186_s12859_020_03922_7 crossref_primary_10_3390_ijms21020612 crossref_primary_10_3988_jcn_2021_17_2_220 crossref_primary_10_1152_jn_00486_2021 crossref_primary_10_1016_j_prp_2024_155165 crossref_primary_10_3171_2017_9_JNS172036 crossref_primary_10_1007_s11033_020_05321_w crossref_primary_10_3389_fneur_2019_00745 crossref_primary_10_1007_s11060_017_2729_9 crossref_primary_10_7717_peerj_7414 crossref_primary_10_1016_j_gene_2019_144126 crossref_primary_10_1093_brain_awad199 crossref_primary_10_1186_s41016_024_00371_6 crossref_primary_10_1016_j_critrevonc_2020_102879 crossref_primary_10_1007_s12031_021_01817_7 crossref_primary_10_1007_s40142_017_0127_4 crossref_primary_10_1016_j_pediatrneurol_2019_08_004 crossref_primary_10_3389_fonc_2020_563901 crossref_primary_10_18632_oncotarget_20372 crossref_primary_10_1186_s12967_021_03083_y crossref_primary_10_3390_cancers12040892 crossref_primary_10_1155_2022_6959237 crossref_primary_10_3390_genes15060707 crossref_primary_10_1080_01616412_2021_1948738 crossref_primary_10_1007_s10552_023_01710_1 crossref_primary_10_1158_1078_0432_CCR_18_4212 crossref_primary_10_4274_tnd_2023_17837 crossref_primary_10_3390_cells9030749 crossref_primary_10_3389_fphar_2019_00772 crossref_primary_10_1186_s12885_023_11650_3 crossref_primary_10_1111_bpa_12720 crossref_primary_10_1016_j_jns_2019_07_026 crossref_primary_10_3389_fnins_2021_783361 crossref_primary_10_1186_s12883_020_01888_w crossref_primary_10_3892_ol_2019_10804 crossref_primary_10_3390_cimb46070412 crossref_primary_10_2217_imt_2017_0122 crossref_primary_10_3390_cancers15041342 crossref_primary_10_1007_s00330_021_08234_9 crossref_primary_10_18632_aging_204048 crossref_primary_10_1007_s11060_019_03154_7 crossref_primary_10_3390_ijms20112658 crossref_primary_10_1016_j_xgen_2023_100340 crossref_primary_10_1007_s12094_018_1831_6 crossref_primary_10_3892_ol_2017_7518 |
Cites_doi | 10.1038/nature10866 10.1002/humu.20937 10.1097/PAS.0b013e31827f9c5e 10.1038/nature11262 10.1038/ng.1004 10.1200/JCO.2012.44.1568 10.1126/science.1257216 10.1200/JCO.2013.51.1766 10.1016/j.ccr.2009.12.020 10.1038/modpathol.2013.90 10.1038/nm.2682 10.1007/s11060-013-1107-5 10.1038/nrc.2016.55 10.1056/NEJMoa1402121 10.3171/2015.1.FOCUS14745 10.1038/ng.1102 10.1038/ng.3004 10.1002/pbc.24891 10.1016/j.ccr.2012.08.024 10.1016/j.cell.2015.12.028 10.1038/nature10898 10.1126/science.1236062 10.1056/NEJMoa0808710 10.1146/annurev-pathol-012615-044208 10.2353/ajpath.2009.080958 10.1007/s00401-012-1031-3 10.1007/s11060-011-0596-3 10.1038/ng.2925 10.1093/neuonc/noq110 10.1227/01.neu.0000430768.25844.4d 10.1002/ijc.24379 10.1016/j.ccr.2010.12.014 10.1371/journal.pone.0133813 10.1126/science.1232245 10.3171/2015.1.FOCUS14755 10.18632/oncotarget.588 10.1158/1078-0432.CCR-10-3349 10.1126/science.1170944 10.18632/oncotarget.3906 10.1126/sciadv.1501354 10.1038/sj.bjc.6605179 10.1016/j.ajpath.2011.06.018 10.1097/NEN.0000000000000240 10.1093/jnci/djq497 10.1007/s00401-011-0802-6 10.1016/j.jocn.2015.05.066 10.1007/s00401-009-0561-9 10.1007/s00401-013-1156-z 10.1186/s40478-014-0180-0 10.1038/nature13387 10.1038/bjc.2014.538 10.1158/1078-0432.CCR-10-0438 10.1097/01.CNE.0000466892.11952.6f 10.1038/nature08617 10.1016/j.brainres.2006.11.093 10.1093/neuonc/not146 10.1001/jamaneurol.2014.1205 10.1200/JCO.2014.58.3922 10.1073/pnas.1008850107 10.1016/j.biocel.2012.01.017 10.1126/science.1234769 10.1128/MCB.01317-14 10.1038/nature10860 10.1186/s12967-014-0356-1 10.1093/neuonc/not159 10.1172/JCI33656 10.1007/s00401-014-1370-3 10.1186/s13059-015-0580-x 10.1007/s11060-013-1176-5 10.1016/S0891-5849(02)00815-8 10.1021/ml300225h 10.1212/WNL.0b013e3181e1cf3a 10.1126/science.1164382 10.1007/s00401-016-1611-8 10.1186/s40478-015-0213-3 10.1038/ng.2938 10.1111/his.12927 10.1016/j.ccr.2010.03.017 10.18632/oncotarget.689 10.1158/1078-0432.CCR-13-3052 10.1073/pnas.1320611111 10.1158/0008-5472.CAN-09-2650 10.1056/NEJMoa1407279 10.1158/1535-7163.TARG-15-PL04-05 10.1038/nature10833 10.1200/JCO.2013.49.3726 10.1073/pnas.1219232110 10.1038/nm.3716 10.1200/JCO.2012.43.2229 10.1038/nm.3855 10.1007/s11060-011-0737-8 10.1126/scitranslmed.3002796 10.1016/j.ccr.2010.11.015 10.1007/s00401-008-0455-2 10.1126/science.1192632 10.1073/pnas.1303607110 10.1016/j.nec.2012.04.009 10.1186/1471-2407-14-258 10.1002/pbc.25787 10.1126/science.1207313 10.1002/jso.23822 10.1126/science.1254257 10.1007/s00401-010-0645-6 10.1126/science.1239947 10.1101/gr.132738.111 10.1182/blood-2013-03-491571 10.1097/NEN.0b013e3181845622 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W 10.1097/PAP.0000000000000049 10.1038/nature16490 10.1200/JCO.2012.46.0220 10.1021/bi200499m 10.1158/1078-0432.CCR-12-3002 10.1038/ng.2950 10.1007/s00401-016-1545-1 10.1038/onc.2009.333 10.1158/1078-0432.CCR-15-0656 10.1002/path.2913 10.1182/blood.V124.21.115.115 10.1016/S0959-8049(14)70722-1 10.1097/01.cne.0000466893.11952.26 10.18632/oncotarget.7650 10.18632/genesandcancer.48 10.1182/blood.V122.21.240.240 10.1038/nrc3811 10.1158/1535-7163.targ-15-pl04-05 10.1007/s12035-016-9930-2 |
ContentType | Journal Article Book Review |
Copyright | Springer Science+Business Media New York 2017 Current Neurology and Neuroscience Reports is a copyright of Springer, 2017. |
Copyright_xml | – notice: Springer Science+Business Media New York 2017 – notice: Current Neurology and Neuroscience Reports is a copyright of Springer, 2017. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7TK 7X7 7XB 88E 88G 8AO 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ K9. M0S M1P M2M PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 |
DOI | 10.1007/s11910-017-0722-5 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Psychology Database (ProQuest) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest One Psychology ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest One Psychology MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1534-6293 |
EndPage | 19 |
ExternalDocumentID | 4319581741 10_1007_s11910_017_0722_5 28271343 |
Genre | Journal Article Review |
GroupedDBID | --- -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 203 29F 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 3V. 4.4 406 408 40D 40E 53G 5GY 5VS 6NX 7X7 875 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AAFGU AAHNG AAIAL AAJKR AANXM AANZL AAPBV AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO ABDZT ABECU ABFGW ABFTV ABHQN ABIPD ABJNI ABJOX ABKAS ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABUWG ABWNU ABXPI ACBMV ACBRV ACBYP ACGFS ACHSB ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACREN ACSNA ACTTH ACVWB ACWMK ADBBV ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEBTG AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFKRA AFLOW AFNRJ AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGGBP AGJBK AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ AXYYD AZQEC B-. BA0 BDATZ BENPR BGNMA BPHCQ BVXVI C1A CAG CCPQU COF CS3 CSCUP CUW DDRTE DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMOBN ESBYG F5P FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 HF~ HG6 HMCUK HMJXF HRMNR HZ~ IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE I~Z J-C JBSCW JZLTJ KOV LLZTM M1P M2M M4Y MA- N9A NPVJJ NQJWS NU0 O9- O9J OVD P9S PF0 PQQKQ PROAC PSQYO PSYQQ PT4 Q2X QOR QOS R89 R9I ROL RPX RSV S16 S1Z S27 S37 S3B SAP SDH SHX SISQX SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 TEORI TSG TSK TSV TUC U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W48 WH7 WK8 YLTOR Z7U Z7W Z82 Z87 ZMTXR ZOVNA ~A9 AACDK AAJBT AASML AAYZH ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU ALIPV CGR CUY CVF ECM EIF H13 NPM SJYHP AAYXX CITATION 7TK 7XB 8FK K9. PQEST PQUKI PRINS Q9U 7X8 |
ID | FETCH-LOGICAL-c438t-eccb8cb2581293bf53354e2a9c1507f508d14bcf85fc0dfdabffe748daf1cedb3 |
IEDL.DBID | BENPR |
ISSN | 1528-4042 |
IngestDate | Sat Aug 17 02:48:38 EDT 2024 Thu Oct 10 15:56:53 EDT 2024 Thu Sep 12 17:03:10 EDT 2024 Wed Oct 16 00:59:17 EDT 2024 Sat Dec 16 11:59:45 EST 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | BRAF Glioma TERT IDH H3K27M ATRX |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c438t-eccb8cb2581293bf53354e2a9c1507f508d14bcf85fc0dfdabffe748daf1cedb3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
PMID | 28271343 |
PQID | 1875059502 |
PQPubID | 326346 |
PageCount | 1 |
ParticipantIDs | proquest_miscellaneous_1875406037 proquest_journals_1875059502 crossref_primary_10_1007_s11910_017_0722_5 pubmed_primary_28271343 springer_journals_10_1007_s11910_017_0722_5 |
PublicationCentury | 2000 |
PublicationDate | 2017-02-01 |
PublicationDateYYYYMMDD | 2017-02-01 |
PublicationDate_xml | – month: 02 year: 2017 text: 2017-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States – name: Philadelphia |
PublicationTitle | Current Neurology and Neuroscience Reports |
PublicationTitleAbbrev | Curr Neurol Neurosci Rep |
PublicationTitleAlternate | Curr Neurol Neurosci Rep |
PublicationYear | 2017 |
Publisher | Springer US Springer Nature B.V |
Publisher_xml | – name: Springer US – name: Springer Nature B.V |
References | Karsy, Sivakumar, Neil, Moy, Jensen (CR11) 2015; 37 Koivunen, Lee, Duncan, Lopez, Lu, Ramkissoon (CR35) 2012; 483 Chaturvedi, Araujo Cruz, Jyotsana, Sharma, Yun, Gorlich (CR56) 2013; 122 Usubalieva, Pierson, Kavran, Huntoon, Kryvenko, Mayer (CR102) 2015; 74 Fontebasso, Papillon-Cavanagh, Schwartzentruber, Nikbakht, Gerges, Fiset (CR117) 2014; 46 Dang, White, Gross, Bennett, Bittinger, Driggers (CR23) 2009; 462 Li, Paz, Wilky, Johnson, Galoian, Rosenberg (CR57) 2015; 10 Christensen, Smith, Zheng, Koestler, Houseman, Marsit (CR30) 2011; 103 Killela, Reitman, Jiao, Bettegowda, Agrawal, Diaz (CR106) 2013; 110 Labussiere, Di Stefano, Gleize, Boisselier, Giry, Mangesius (CR111) 2014; 111 Ohgaki, Kleihues (CR3) 2013; 19 Eckel-Passow, Lachance, Molinaro, Walsh, Decker, Sicotte (CR6) 2015; 372 Turcan, Rohle, Goenka, Walsh, Fang, Yilmaz (CR33) 2012; 483 Tabouret, Nguyen, Dehais, Carpentier, Ducray, Idbaih (CR45) 2016; 132 Mellai, Piazzi, Caldera, Monzeglio, Cassoni, Valente (CR20) 2011; 105 Cairncross, Wang, Jenkins, Shaw, Giannini, Brachman (CR47) 2014; 32 Rohle, Popovici-Muller, Palaskas, Turcan, Grommes, Campos (CR63) 2013; 340 Kannan, Inagaki, Silber, Gorovets, Zhang, Kastenhuber (CR70) 2012; 3 Shin, Grossmann, Holmen, Robinson (CR93) 2015; 6 Sievert, Lang, Boucher, Madsen, Slaunwhite, Choudhari (CR104) 2013; 110 Kranendijk, Struys, van Schaftingen, Gibson, Kanhai, van der Knaap (CR22) 2010; 330 Hartmann, Meyer, Balss, Capper, Mueller, Christians (CR14) 2009; 118 Elkhaled, Jalbert, Phillips, Yoshihara, Parvataneni, Srinivasan (CR49) 2012; 4 Eid, Demattei, Episkopou, Auge-Gouillou, Decottignies, Grandin (CR78) 2015; 35 Raabe, Lim, Kim, Meeker, Mao, Nikkhah (CR94) 2011; 17 Meyer, Reimand, Lan, Head, Zhu, Kushida (CR126) 2015; 112 Popovici-Muller, Saunders, Salituro, Travins, Yan, Zhao (CR55) 2012; 3 Walsh, Codd, Smirnov, Rice, Decker, Hansen (CR108) 2014; 46 Labussiere, Idbaih, Wang, Marie, Boisselier, Falet (CR42) 2010; 74 Wu, Diaz, Paugh, Rankin, Ju, Li (CR68) 2014; 46 Parsons, Jones, Zhang, Lin, Leary, Angenendt (CR7) 2008; 321 Lee, Koh, Park, Song, Huh, Park (CR25) 2002; 32 Andronesi, Loebel, Bogner, Marjanska, Vander Heiden, Iafrate (CR52) 2016; 22 Wu, Broniscer, McEachron, Lu, Paugh, Becksfort (CR115) 2012; 44 Taylor, Mackay, Truffaux, Butterfield, Morozova, Philippe (CR120) 2014; 46 Flavahan, Drier, Liau, Gillespie, Venteicher, Stemmer-Rachamimov (CR38) 2016; 529 Hashizume, Andor, Ihara, Lerner, Gan, Chen (CR122) 2014; 20 Karsy, Neil, Guan, Mahan, Colman, Jensen (CR41) 2015; 38 Turkalp, Karamchandani, Das (CR17) 2014; 71 CR59 Schumacher, Bunse, Pusch, Sahm, Wiestler, Quandt (CR65) 2014; 512 Kang, Kim, Oh, Kim, Song, Seo (CR15) 2009; 125 Grasso, Tang, Truffaux, Berlow, Liu, Debily (CR121) 2015; 21 Schindler, Capper, Meyer, Janzarik, Omran, Herold-Mende (CR85) 2011; 121 Lang (CR103) 2013; 60 Fu, Zheng, Zheng, Huang, An, Liang (CR34) 2012; 44 Ikemura, Shibahara, Mukasa, Takayanagi, Aihara, Saito (CR72) 2016; 69 Bleeker, Atai, Lamba, Jonker, Rijkeboer, Bosch (CR18) 2010; 119 del Bufalo, Carai, Figa-Talamanca, Pettorini, Mallucci, Giangaspero (CR98) 2014; 12 Yuan, Qi, Maling, Xiang, Yanhui, Ruofei (CR110) 2016; 26 Figueroa, Abdel-Wahab, Lu, Ward, Patel, Shih (CR27) 2010; 18 Abedalthagafi, Phillips, Kim, Mueller, Haas-Kogen, Marshall (CR76) 2013; 26 Bleeker, Lamba, Leenstra, Troost, Hulsebos, Vandertop (CR13) 2009; 30 Arndt, MacKenzie (CR105) 2016; 16 Balss, Meyer, Mueller, Korshunov, Hartmann, von Deimling (CR12) 2008; 116 Lewis, Muller, Koletsky, Cordero, Lin, Banaszynski (CR118) 2013; 340 Chi, Batchelor, Yang, Dias-Santagata, Borger, Ellisen (CR83) 2013; 31 Bautista, Paci, Minard-Colin, Dufour, Grill, Lacroix (CR96) 2014; 61 Watanabe, Nobusawa, Kleihues, Ohgaki (CR19) 2009; 174 Schwartzentruber, Korshunov, Liu, Jones, Pfaff, Jacob (CR67) 2012; 482 Brat, Verhaak, Aldape, Yung, Salama, Cooper (CR4) 2015; 372 Rush, Foreman, Liu (CR101) 2013; 31 CR62 Ceccarelli, Barthel, Malta, Sabedot, Salama, Murray (CR5) 2016; 164 Amary, Bacsi, Maggiani, Damato, Halai, Berisha (CR39) 2011; 224 Pellegatta, Valletta, Corbetta, Patane, Zucca, Riccardi Sirtori (CR64) 2015; 3 Heaphy, de Wilde, Jiao, Klein, Edil, Shi (CR66) 2011; 333 Sun, Yin, Li, Han, Song, Liu (CR46) 2013; 113 Bax, Mackay, Little, Carvalho, Viana-Pereira, Tamber (CR119) 2010; 16 Yan, Bigner, Velculescu, Parsons (CR26) 2009; 69 Wakimoto, Tanaka, Curry, Loebel, Zhao, Tateishi (CR43) 2014; 20 Lewis, Elsaesser, Noh, Stadler, Allis (CR75) 2010; 107 Beiko, Suki, Hess, Fox, Cheung, Cabral (CR53) 2014; 16 Laffaire, Everhard, Idbaih, Criniere, Marie, de Reynies (CR31) 2011; 13 Verhaak, Hoadley, Purdom, Wang, Qi, Wilkerson (CR8) 2010; 17 Jiao, Killela, Reitman, Rasheed, Heaphy, de Wilde (CR69) 2012; 3 Cai, Zhu, Zhang, Li, Wang, Li (CR74) 2016; 7 CR114 Pfister, Janzarik, Remke, Ernst, Werft, Becker (CR89) 2008; 118 Aguilera, Janss, Mazewski, Castellino, Schniederjan, Hayes (CR95) 2016; 63 Choi, Ganji, DeBerardinis, Hatanpaa, Rakheja, Kovacs (CR50) 2012; 18 Heaphy, Subhawong, Hong, Goggins, Montgomery, Gabrielson (CR77) 2011; 179 Bar, Lin, Tihan, Burger, Eberhart (CR87) 2008; 67 Chamberlain (CR97) 2013; 114 Kim, Liau (CR16) 2012; 23 van den Bent, Brandes, Taphoorn, Kros, Kouwenhoven, Delattre (CR48) 2013; 31 Dahiya, Emnett, Haydon, Leonard, Phillips, Perry (CR84) 2014; 16 Xu, Yang, Liu, Yang, Wang, Kim (CR28) 2011; 19 Wiestler, Capper, Holland-Letz, Korshunov, von Deimling, Pfister (CR81) 2013; 126 Kruidenier, Chung, Cheng, Liddle, Che, Joberty (CR123) 2012; 488 Zhao, Lin, Xu, Jiang, Zha, Wang (CR36) 2009; 324 Filbin, Suva (CR112) 2016; 11 Patel, Tirosh, Trombetta, Shalek, Gillespie, Wakimoto (CR124) 2014; 344 Chen, Ravindra, Cohen, Jensen, Salzman, Prescot (CR44) 2015; 38 Pope, Prins, Albert Thomas, Nagarajan, Yen, Bittinger (CR51) 2012; 107 Mistry, Zhukova, Merico, Rakopoulos, Krishnatry, Shago (CR91) 2015; 33 Efroni, Ip, Nawy, Mello, Birnbaum (CR125) 2015; 16 Wang, Travins, DeLaBarre, Penard-Lacronique, Schalm, Hansen (CR60) 2013; 340 Jacob, Albrecht, Sollier, Faury, Sader, Montpetit (CR88) 2009; 101 Noushmehr, Weisenberger, Diefes, Phillips, Pujara, Berman (CR32) 2010; 17 Duncan, Barwick, Jin, Rago, Kapoor-Vazirani, Powell (CR21) 2012; 22 Lu, Ward, Kapoor, Rohle, Turcan, Abdel-Wahab (CR29) 2012; 483 Liu, Gerges, Korshunov, Sabha, Khuong-Quang, Fontebasso (CR71) 2012; 124 Cohen, Sato, Aldape, Mason, Alfaro-Munoz, Heathcock (CR37) 2015; 3 Fujii, Khawaja, DiNardo, Atkins, Janku (CR54) 2016; 21 Kleinschmidt-DeMasters, Aisner, Birks, Foreman (CR90) 2013; 37 Cai, Chen, Zhang, Yang, Zhang, Li (CR80) 2015; 6 Lee, Ruland, LeBoeuf, Wen, Santagata (CR99) 2016; 34 Pietrak, Zhao, Qi, Quinn, Gao, Boyer (CR24) 2011; 50 Pansuriya, van Eijk, d’Adamo, van Ruler, Kuijjer, Oosting (CR40) 2011; 43 Flynn, Cox, Jeitany, Wakimoto, Bryll, Ganem (CR79) 2015; 347 Robinson, VanBrocklin, Guilbeault, Signorelli, Brandner, Holmen (CR92) 2010; 29 Reuss, Sahm, Schrimpf, Wiestler, Capper, Koelsche (CR82) 2015; 129 Sturm, Witt, Hovestadt, Khuong-Quang, Jones, Konermann (CR116) 2012; 22 Yan, Parsons, Jin, McLendon, Rasheed, Yuan (CR10) 2009; 360 Johnson, Mazor, Hong, Barnes, Aihara, McLean (CR9) 2014; 343 Venneti, Huse (CR73) 2015; 22 Louis, Perry, Reifenberger, von Deimling, Figarella-Branger, Cavenee (CR1) 2016; 131 Yen, Wang, Travins, Chen, Yang, Straley (CR61) 2013; 122 Lulla, Saratsis, Hashizume (CR113) 2016; 2 Robinson, Orr, Gajjar (CR100) 2014; 14 Shervington, Patel, Lu, Cruickshanks, Lea, Roberts (CR107) 2007; 1134 Coons, Johnson, Scheithauer, Yates, Pearl (CR2) 1997; 79 Lee, Cho, Kang, Yoon, Sung, Suh (CR86) 2015; 111 Burris, Mellinghoff, Maher, Wen, Beeram, Touat (CR58) 2015; 14 CR109 23552385 - Am J Surg Pathol. 2013 May;37(5):685-98 20427748 - Neurology. 2010 Jun 8;74(23):1886-90 25043048 - Nature. 2014 Aug 21;512(7514):324-7 19117336 - Hum Mutat. 2009 Jan;30(1):7-11 24714777 - Clin Cancer Res. 2014 Jun 1;20(11):2898-909 23756728 - J Neurooncol. 2013 Sep;114(2):237-40 23539183 - Science. 2013 May 17;340(6134):857-61 25821557 - Genes Cancer. 2015 Jan;6(1-2):9-18 22842901 - Nature. 2012 Aug 16;488(7411):404-8 25667294 - J Clin Oncol. 2015 Mar 20;33(9):1015-22 19855433 - Oncogene. 2010 Jan 21;29(3):335-44 18398503 - J Clin Invest. 2008 May;118(5):1739-49 19996293 - Cancer Res. 2009 Dec 15;69(24):9157-9 25230881 - Nat Rev Cancer. 2014 Oct;14(10):null 26824661 - Cell. 2016 Jan 28;164(3):550-63 23209033 - Clin Cancer Res. 2013 Feb 15;19(4):764-72 9083161 - Cancer. 1997 Apr 1;79(7):1381-93 26055325 - Mol Cell Biol. 2015 Aug;35(16):2818-30 24925914 - Science. 2014 Jun 20;344(6190):1396-401 22238333 - Sci Transl Med. 2012 Jan 11;4(116):116ra5 22057234 - Nat Genet. 2011 Nov 06;43(12):1256-61 25849072 - Acta Neuropathol Commun. 2015 Jan 21;3:4 27034984 - Sci Adv. 2016 Mar 18;2(3):e1501354 20127344 - Acta Neuropathol. 2010 Apr;119(4):487-94 23558169 - Science. 2013 May 3;340(6132):626-30 23358987 - J Clin Oncol. 2013 Apr 1;31(10 ):e159-60 27339602 - Nat Rev Cancer. 2016 Aug;16(8):508-24 23904111 - Acta Neuropathol. 2013 Sep;126(3):443-51 24725538 - BMC Cancer. 2014 Apr 12;14 :258 22343896 - Nature. 2012 Feb 15;483(7390):484-8 22343889 - Nature. 2012 Feb 15;483(7390):479-83 22015945 - J Neurooncol. 2012 Mar;107(1):197-205 26741321 - Histopathology. 2016 Aug;69(2):260-7 25608970 - Genome Biol. 2015 Jan 22;16:9 24516018 - J Clin Oncol. 2014 Mar 10;32(8):783-90 20847235 - Science. 2010 Oct 15;330(6002):336 21643842 - J Neurooncol. 2011 Nov;105(2):345-57 20651253 - Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14075-80 23547069 - J Clin Oncol. 2013 May 10;31(14):e233-6 23104868 - Oncotarget. 2012 Oct;3(10):1194-203 26091668 - Acta Neuropathol Commun. 2015 Jun 20;3:34 19603027 - Br J Cancer. 2009 Aug 18;101(4):722-33 19935646 - Nature. 2009 Dec 10;462(7274):739-44 23530248 - Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6021-6 22309944 - Int J Biochem Cell Biol. 2012 May;44(5):770-5 25664944 - Adv Anat Pathol. 2015 Mar;22(2):94-101 18772396 - Science. 2008 Sep 26;321(5897):1807-12 24705252 - Nat Genet. 2014 May;46(5):457-461 25401693 - Nat Med. 2014 Dec;20(12):1394-6 20129251 - Cancer Cell. 2010 Jan 19;17(1):98-110 26368816 - PLoS One. 2015 Sep 14;10(9):e0133813 21130701 - Cancer Cell. 2010 Dec 14;18(6):553-67 26579623 - Pediatr Blood Cancer. 2016 Mar;63(3):541-3 21888887 - Am J Pathol. 2011 Oct;179(4):1608-15 25593184 - Science. 2015 Jan 16;347(6219):273-7 26352988 - J Neuropathol Exp Neurol. 2015 Oct;74(10):960-9 21598255 - J Pathol. 2011 Jul;224(3):334-43 23558173 - Science. 2013 May 3;340(6132):622-6 18716556 - J Neuropathol Exp Neurol. 2008 Sep;67(9):878-87 22281806 - Nat Med. 2012 Jan 26;18(4):624-9 25092772 - J Clin Oncol. 2016 Apr 1;34(10 ):e87-9 26061753 - N Engl J Med. 2015 Jun 25;372(26):2499-508 24908248 - Nat Genet. 2014 Jul;46(7):731-5 25971279 - Oncotarget. 2015 Jul 20;6(20):18105-15 26534967 - Clin Cancer Res. 2016 Apr 1;22(7):1632-41 25561528 - Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):851-6 12031902 - Free Radic Biol Med. 2002 Jun 1;32(11):1185-96 22748659 - Neurosurg Clin N Am. 2012 Jul;23(3):471-80 19554337 - Acta Neuropathol. 2009 Oct;118(4):469-74 25155243 - JAMA Neurol. 2014 Oct;71(10):1319-25 21251613 - Cancer Cell. 2011 Jan 18;19(1):17-30 22286061 - Nature. 2012 Jan 29;482(7384):226-31 26700815 - Nature. 2016 Jan 7;529(7584):110-4 23071237 - J Clin Oncol. 2013 Jan 20;31(3):344-50 21524095 - Biochemistry. 2011 May 31;50(21):4804-12 21636552 - Clin Cancer Res. 2011 Jun 1;17(11):3590-9 24375920 - Pediatr Blood Cancer. 2014 Jun;61(6):1101-3 25524464 - J Transl Med. 2014 Dec 19;12 :356 24900389 - ACS Med Chem Lett. 2012 Sep 17;3(10):850-5 21163902 - J Natl Cancer Inst. 2011 Jan 19;103(2):143-53 26765760 - J Clin Neurosci. 2016 Apr;26:57-62 19378339 - Int J Cancer. 2009 Jul 15;125(2):353-5 22899282 - Genome Res. 2012 Dec;22(12):2339-55 25314060 - Br J Cancer. 2014 Nov 11;111(10):2024-32 19228619 - N Engl J Med. 2009 Feb 19;360(8):765-73 25727224 - Neurosurg Focus. 2015 Mar;38(3):E2 25346165 - J Surg Oncol. 2015 Mar;111(3):359-64 18985363 - Acta Neuropathol. 2008 Dec;116(6):597-602 22286216 - Nat Genet. 2012 Jan 29;44(3):251-3 24311634 - Neuro Oncol. 2014 Jan;16(2):318-9 22886134 - Acta Neuropathol. 2012 Nov;124(5):615-25 25427834 - Acta Neuropathol. 2015 Jan;129(1):133-46 19359588 - Science. 2009 Apr 10;324(5924):261-5 26980161 - Annu Rev Pathol. 2016 May 23;11:497-521 20570930 - Clin Cancer Res. 2010 Jul 1;16(13):3368-77 20399149 - Cancer Cell. 2010 May 18;17(5):510-22 23533272 - Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):5957-62 23079654 - Cancer Cell. 2012 Oct 16;22(4):425-37 21274720 - Acta Neuropathol. 2011 Mar;121(3):397-405 21719641 - Science. 2011 Jul 22;333(6041):425 27573687 - Acta Neuropathol. 2016 Oct;132(4):625-34 27157931 - Acta Neuropathol. 2016 Jun;131(6):803-20 22343901 - Nature. 2012 Feb 15;483(7390):474-8 20926426 - Neuro Oncol. 2011 Jan;13(1):84-98 26061751 - N Engl J Med. 2015 Jun 25;372(26):2481-98 24305719 - Neuro Oncol. 2014 Jan;16(1):81-91 25727226 - Neurosurg Focus. 2015 Mar;38(3):E4 23765250 - Mod Pathol. 2013 Nov;26(11):1425-32 23954893 - Blood. 2013 Oct 17;122(16):2877-87 27355333 - Discov Med. 2016 May;21(117):373-80 24336570 - Science. 2014 Jan 10;343 (6167):189-193 23504258 - J Neurooncol. 2013 Jun;113(2):277-84 23839361 - Neurosurgery. 2013 Aug;60 Suppl 1:110-2 25939062 - Nat Med. 2015 Jun;21(6):555-9 17196947 - Brain Res. 2007 Feb 23;1134(1):45-52 19246647 - Am J Pathol. 2009 Apr;174(4):1149-53 24705251 - Nat Genet. 2014 May;46(5):444-450 22869205 - Oncotarget. 2012 Jul;3(7):709-22 26918938 - Oncotarget. 2016 Mar 29;7(13):16384-95 27206431 - Mol Neurobiol. 2017 Jul;54(5):3665-3669 24705250 - Nat Genet. 2014 May;46(5):462-6 J Popovici-Muller (722_CR55) 2012; 3 S Rush (722_CR101) 2013; 31 MF Amary (722_CR39) 2011; 224 A Elkhaled (722_CR49) 2012; 4 CM Heaphy (722_CR66) 2011; 333 WA Flavahan (722_CR38) 2016; 529 S Pfister (722_CR89) 2008; 118 M Ikemura (722_CR72) 2016; 69 H Yan (722_CR26) 2009; 69 S Zhao (722_CR36) 2009; 324 EH Raabe (722_CR94) 2011; 17 BE Johnson (722_CR9) 2014; 343 W Kim (722_CR16) 2012; 23 JP Robinson (722_CR92) 2010; 29 AM Fontebasso (722_CR117) 2014; 46 GM Arndt (722_CR105) 2016; 16 M Mistry (722_CR91) 2015; 33 722_CR114 EQ Lee (722_CR99) 2016; 34 DJ Brat (722_CR4) 2015; 372 M Karsy (722_CR41) 2015; 38 G Wu (722_CR115) 2012; 44 D Aguilera (722_CR95) 2016; 63 MG Filbin (722_CR112) 2016; 11 FE Bleeker (722_CR18) 2010; 119 722_CR109 I Efroni (722_CR125) 2015; 16 T Watanabe (722_CR19) 2009; 174 S Venneti (722_CR73) 2015; 22 TC Pansuriya (722_CR40) 2011; 43 L Li (722_CR57) 2015; 10 F Wang (722_CR60) 2013; 340 JE Eckel-Passow (722_CR6) 2015; 372 D Lee (722_CR86) 2015; 111 S Dahiya (722_CR84) 2014; 16 BK Kleinschmidt-DeMasters (722_CR90) 2013; 37 A Usubalieva (722_CR102) 2015; 74 AJ Sievert (722_CR104) 2013; 110 D Sturm (722_CR116) 2012; 22 M Labussiere (722_CR42) 2010; 74 K Jacob (722_CR88) 2009; 101 J Schwartzentruber (722_CR67) 2012; 482 P Koivunen (722_CR35) 2012; 483 K Kannan (722_CR70) 2012; 3 AS Chi (722_CR83) 2013; 31 G Wu (722_CR68) 2014; 46 RL Flynn (722_CR79) 2015; 347 EE Bar (722_CR87) 2008; 67 PW Lewis (722_CR118) 2013; 340 M Mellai (722_CR20) 2011; 105 L Dang (722_CR23) 2009; 462 AP Patel (722_CR124) 2014; 344 ME Figueroa (722_CR27) 2010; 18 W Xu (722_CR28) 2011; 19 R Hashizume (722_CR122) 2014; 20 BC Christensen (722_CR30) 2011; 103 B Pietrak (722_CR24) 2011; 50 J Cai (722_CR74) 2016; 7 DA Bax (722_CR119) 2010; 16 B Wiestler (722_CR81) 2013; 126 SS Lang (722_CR103) 2013; 60 C Hartmann (722_CR14) 2009; 118 OC Andronesi (722_CR52) 2016; 22 G Schindler (722_CR85) 2011; 121 CS Grasso (722_CR121) 2015; 21 CG Duncan (722_CR21) 2012; 22 DW Parsons (722_CR7) 2008; 321 H Sun (722_CR46) 2013; 113 MC Chamberlain (722_CR97) 2013; 114 H Yan (722_CR10) 2009; 360 F Bautista (722_CR96) 2014; 61 M Kranendijk (722_CR22) 2010; 330 A Shervington (722_CR107) 2007; 1134 M Meyer (722_CR126) 2015; 112 H Burris (722_CR58) 2015; 14 H Wakimoto (722_CR43) 2014; 20 M Abedalthagafi (722_CR76) 2013; 26 RG Verhaak (722_CR8) 2010; 17 DE Reuss (722_CR82) 2015; 129 FE Bleeker (722_CR13) 2009; 30 RR Lulla (722_CR113) 2016; 2 H Noushmehr (722_CR32) 2010; 17 XY Liu (722_CR71) 2012; 124 MR Kang (722_CR15) 2009; 125 S Turcan (722_CR33) 2012; 483 GW Robinson (722_CR100) 2014; 14 SW Coons (722_CR2) 1997; 79 MJ Bent van den (722_CR48) 2013; 31 D Rohle (722_CR63) 2013; 340 F Bufalo del (722_CR98) 2014; 12 C Choi (722_CR50) 2012; 18 PW Lewis (722_CR75) 2010; 107 J Laffaire (722_CR31) 2011; 13 K Yen (722_CR61) 2013; 122 J Cai (722_CR80) 2015; 6 CM Heaphy (722_CR77) 2011; 179 M Labussiere (722_CR111) 2014; 111 C Lu (722_CR29) 2012; 483 PJ Killela (722_CR106) 2013; 110 J Beiko (722_CR53) 2014; 16 J Balss (722_CR12) 2008; 116 722_CR59 T Schumacher (722_CR65) 2014; 512 H Ohgaki (722_CR3) 2013; 19 JG Cairncross (722_CR47) 2014; 32 S Pellegatta (722_CR64) 2015; 3 Y Yuan (722_CR110) 2016; 26 M Ceccarelli (722_CR5) 2016; 164 A Cohen (722_CR37) 2015; 3 R Eid (722_CR78) 2015; 35 L Kruidenier (722_CR123) 2012; 488 Z Turkalp (722_CR17) 2014; 71 WB Pope (722_CR51) 2012; 107 CH Shin (722_CR93) 2015; 6 KM Walsh (722_CR108) 2014; 46 SM Lee (722_CR25) 2002; 32 T Fujii (722_CR54) 2016; 21 KR Taylor (722_CR120) 2014; 46 A Chaturvedi (722_CR56) 2013; 122 E Tabouret (722_CR45) 2016; 132 722_CR62 Y Jiao (722_CR69) 2012; 3 R Chen (722_CR44) 2015; 38 M Karsy (722_CR11) 2015; 37 Y Fu (722_CR34) 2012; 44 DN Louis (722_CR1) 2016; 131 |
References_xml | – volume: 483 start-page: 479 issue: 7390 year: 2012 end-page: 83 ident: CR33 article-title: IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype publication-title: Nature doi: 10.1038/nature10866 contributor: fullname: Yilmaz – volume: 30 start-page: 7 issue: 1 year: 2009 end-page: 11 ident: CR13 article-title: IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors publication-title: Hum Mutat doi: 10.1002/humu.20937 contributor: fullname: Vandertop – volume: 37 start-page: 685 issue: 5 year: 2013 end-page: 98 ident: CR90 article-title: Epithelioid GBMs show a high percentage of BRAF V600E mutation publication-title: Am J Surg Pathol doi: 10.1097/PAS.0b013e31827f9c5e contributor: fullname: Foreman – volume: 488 start-page: 404 issue: 7411 year: 2012 end-page: 8 ident: CR123 article-title: A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response publication-title: Nature doi: 10.1038/nature11262 contributor: fullname: Joberty – volume: 43 start-page: 1256 issue: 12 year: 2011 end-page: 61 ident: CR40 article-title: Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome publication-title: Nat Genet doi: 10.1038/ng.1004 contributor: fullname: Oosting – volume: 31 start-page: e159 issue: 10 year: 2013 end-page: 60 ident: CR101 article-title: Brainstem ganglioglioma successfully treated with vemurafenib publication-title: J Clin Oncol doi: 10.1200/JCO.2012.44.1568 contributor: fullname: Liu – volume: 347 start-page: 273 issue: 6219 year: 2015 end-page: 7 ident: CR79 article-title: Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors publication-title: Science doi: 10.1126/science.1257216 contributor: fullname: Ganem – volume: 34 start-page: e87 issue: 10 year: 2016 end-page: 9 ident: CR99 article-title: Successful treatment of a progressive BRAF V600E-mutated anaplastic pleomorphic xanthoastrocytoma with vemurafenib monotherapy publication-title: J Clin Oncol doi: 10.1200/JCO.2013.51.1766 contributor: fullname: Santagata – volume: 17 start-page: 98 issue: 1 year: 2010 end-page: 110 ident: CR8 article-title: Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 publication-title: Cancer Cell doi: 10.1016/j.ccr.2009.12.020 contributor: fullname: Wilkerson – volume: 6 start-page: 9 issue: 1-2 year: 2015 end-page: 18 ident: CR93 article-title: The BRAF kinase domain promotes the development of gliomas in vivo publication-title: Genes Cancer contributor: fullname: Robinson – volume: 26 start-page: 1425 issue: 11 year: 2013 end-page: 32 ident: CR76 article-title: The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas publication-title: Mod Pathol doi: 10.1038/modpathol.2013.90 contributor: fullname: Marshall – volume: 18 start-page: 624 issue: 4 year: 2012 end-page: 9 ident: CR50 article-title: 2-Hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas publication-title: Nat Med doi: 10.1038/nm.2682 contributor: fullname: Kovacs – volume: 113 start-page: 277 issue: 2 year: 2013 end-page: 84 ident: CR46 article-title: Prognostic significance of IDH mutation in adult low-grade gliomas: a meta-analysis publication-title: J Neurooncol doi: 10.1007/s11060-013-1107-5 contributor: fullname: Liu – volume: 16 start-page: 508 issue: 8 year: 2016 end-page: 24 ident: CR105 article-title: New prospects for targeting telomerase beyond the telomere publication-title: Nat Rev Cancer doi: 10.1038/nrc.2016.55 contributor: fullname: MacKenzie – volume: 372 start-page: 2481 issue: 26 year: 2015 end-page: 98 ident: CR4 article-title: Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas publication-title: N Engl J Med doi: 10.1056/NEJMoa1402121 contributor: fullname: Cooper – volume: 38 start-page: E2 issue: 3 year: 2015 ident: CR44 article-title: Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas publication-title: Neurosurg Focus doi: 10.3171/2015.1.FOCUS14745 contributor: fullname: Prescot – volume: 44 start-page: 251 issue: 3 year: 2012 end-page: 3 ident: CR115 article-title: Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas publication-title: Nat Genet doi: 10.1038/ng.1102 contributor: fullname: Becksfort – volume: 46 start-page: 731 issue: 7 year: 2014 end-page: 5 ident: CR108 article-title: Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk publication-title: Nat Genet doi: 10.1038/ng.3004 contributor: fullname: Hansen – volume: 61 start-page: 1101 issue: 6 year: 2014 end-page: 3 ident: CR96 article-title: Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomas publication-title: Pediatr Blood Cancer doi: 10.1002/pbc.24891 contributor: fullname: Lacroix – volume: 22 start-page: 425 issue: 4 year: 2012 end-page: 37 ident: CR116 article-title: Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma publication-title: Cancer Cell doi: 10.1016/j.ccr.2012.08.024 contributor: fullname: Konermann – volume: 164 start-page: 550 issue: 3 year: 2016 end-page: 63 ident: CR5 article-title: Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma publication-title: Cell doi: 10.1016/j.cell.2015.12.028 contributor: fullname: Murray – volume: 483 start-page: 484 issue: 7390 year: 2012 end-page: 8 ident: CR35 article-title: Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation publication-title: Nature doi: 10.1038/nature10898 contributor: fullname: Ramkissoon – volume: 340 start-page: 626 issue: 6132 year: 2013 end-page: 30 ident: CR63 article-title: An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells publication-title: Science doi: 10.1126/science.1236062 contributor: fullname: Campos – volume: 360 start-page: 765 issue: 8 year: 2009 end-page: 73 ident: CR10 article-title: IDH1 and IDH2 mutations in gliomas publication-title: N Engl J Med doi: 10.1056/NEJMoa0808710 contributor: fullname: Yuan – volume: 11 start-page: 497 year: 2016 end-page: 521 ident: CR112 article-title: Gliomas genomics and epigenomics: arriving at the start and knowing it for the first time publication-title: Annu Rev Pathol doi: 10.1146/annurev-pathol-012615-044208 contributor: fullname: Suva – volume: 174 start-page: 1149 issue: 4 year: 2009 end-page: 53 ident: CR19 article-title: IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas publication-title: Am J Pathol doi: 10.2353/ajpath.2009.080958 contributor: fullname: Ohgaki – volume: 124 start-page: 615 issue: 5 year: 2012 end-page: 25 ident: CR71 article-title: Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations publication-title: Acta Neuropathol doi: 10.1007/s00401-012-1031-3 contributor: fullname: Fontebasso – volume: 105 start-page: 345 issue: 2 year: 2011 end-page: 57 ident: CR20 article-title: IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors publication-title: J Neurooncol doi: 10.1007/s11060-011-0596-3 contributor: fullname: Valente – volume: 46 start-page: 457 issue: 5 year: 2014 end-page: 61 ident: CR120 article-title: Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma publication-title: Nat Genet doi: 10.1038/ng.2925 contributor: fullname: Philippe – volume: 13 start-page: 84 issue: 1 year: 2011 end-page: 98 ident: CR31 article-title: Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis publication-title: Neuro Oncol doi: 10.1093/neuonc/noq110 contributor: fullname: de Reynies – volume: 60 start-page: 110 issue: Suppl 1 year: 2013 end-page: 2 ident: CR103 article-title: The role of BRAF-targeted therapy in astrocytomas: a review publication-title: Neurosurgery doi: 10.1227/01.neu.0000430768.25844.4d contributor: fullname: Lang – volume: 125 start-page: 353 issue: 2 year: 2009 end-page: 5 ident: CR15 article-title: Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers publication-title: Int J Cancer doi: 10.1002/ijc.24379 contributor: fullname: Seo – volume: 19 start-page: 17 issue: 1 year: 2011 end-page: 30 ident: CR28 article-title: Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases publication-title: Cancer Cell doi: 10.1016/j.ccr.2010.12.014 contributor: fullname: Kim – volume: 10 start-page: e0133813 issue: 9 year: 2015 ident: CR57 article-title: Treatment with a small molecule mutant IDH1 inhibitor suppresses tumorigenic activity and decreases production of the oncometabolite 2-hydroxyglutarate in human chondrosarcoma cells publication-title: PLoS One doi: 10.1371/journal.pone.0133813 contributor: fullname: Rosenberg – volume: 340 start-page: 857 issue: 6134 year: 2013 end-page: 61 ident: CR118 article-title: Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma publication-title: Science doi: 10.1126/science.1232245 contributor: fullname: Banaszynski – volume: 38 start-page: E4 issue: 3 year: 2015 ident: CR41 article-title: A practical review of prognostic correlations of molecular biomarkers in glioblastoma publication-title: Neurosurg Focus doi: 10.3171/2015.1.FOCUS14755 contributor: fullname: Jensen – volume: 3 start-page: 709 issue: 7 year: 2012 end-page: 22 ident: CR69 article-title: Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas publication-title: Oncotarget doi: 10.18632/oncotarget.588 contributor: fullname: de Wilde – volume: 17 start-page: 3590 issue: 11 year: 2011 end-page: 9 ident: CR94 article-title: BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-10-3349 contributor: fullname: Nikkhah – volume: 324 start-page: 261 issue: 5924 year: 2009 end-page: 5 ident: CR36 article-title: Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha publication-title: Science doi: 10.1126/science.1170944 contributor: fullname: Wang – volume: 6 start-page: 18105 issue: 20 year: 2015 end-page: 15 ident: CR80 article-title: Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors publication-title: Oncotarget doi: 10.18632/oncotarget.3906 contributor: fullname: Li – ident: CR109 – volume: 2 start-page: e1501354 issue: 3 year: 2016 ident: CR113 article-title: Mutations in chromatin machinery and pediatric high-grade glioma publication-title: Sci Adv doi: 10.1126/sciadv.1501354 contributor: fullname: Hashizume – volume: 101 start-page: 722 issue: 4 year: 2009 end-page: 33 ident: CR88 article-title: Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours publication-title: Br J Cancer doi: 10.1038/sj.bjc.6605179 contributor: fullname: Montpetit – volume: 179 start-page: 1608 issue: 4 year: 2011 end-page: 15 ident: CR77 article-title: Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes publication-title: Am J Pathol doi: 10.1016/j.ajpath.2011.06.018 contributor: fullname: Gabrielson – volume: 74 start-page: 960 issue: 10 year: 2015 end-page: 9 ident: CR102 article-title: Primary meningeal pleomorphic xanthoastrocytoma with anaplastic features: a report of 2 cases, one with BRAF(V600E) mutation and clinical response to the BRAF inhibitor dabrafenib publication-title: J Neuropathol Exp Neurol doi: 10.1097/NEN.0000000000000240 contributor: fullname: Mayer – volume: 103 start-page: 143 issue: 2 year: 2011 end-page: 53 ident: CR30 article-title: DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djq497 contributor: fullname: Marsit – volume: 121 start-page: 397 issue: 3 year: 2011 end-page: 405 ident: CR85 article-title: Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma publication-title: Acta Neuropathol doi: 10.1007/s00401-011-0802-6 contributor: fullname: Herold-Mende – volume: 26 start-page: 57 year: 2016 end-page: 62 ident: CR110 article-title: TERT mutation in glioma: frequency, prognosis and risk publication-title: J Clin Neurosci doi: 10.1016/j.jocn.2015.05.066 contributor: fullname: Ruofei – volume: 118 start-page: 469 issue: 4 year: 2009 end-page: 74 ident: CR14 article-title: Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas publication-title: Acta Neuropathol doi: 10.1007/s00401-009-0561-9 contributor: fullname: Christians – volume: 126 start-page: 443 issue: 3 year: 2013 end-page: 51 ident: CR81 article-title: ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis publication-title: Acta Neuropathol doi: 10.1007/s00401-013-1156-z contributor: fullname: Pfister – volume: 3 start-page: 4 year: 2015 ident: CR64 article-title: Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma publication-title: Acta Neuropathol Commun doi: 10.1186/s40478-014-0180-0 contributor: fullname: Riccardi Sirtori – volume: 122 start-page: 240 issue: 21 year: 2013 ident: CR61 article-title: AG-221 offers a survival advantage in a primary human IDH2 mutant AML xenograft model publication-title: Blood contributor: fullname: Straley – volume: 512 start-page: 324 issue: 7514 year: 2014 end-page: 7 ident: CR65 article-title: A vaccine targeting mutant IDH1 induces antitumour immunity publication-title: Nature doi: 10.1038/nature13387 contributor: fullname: Quandt – volume: 111 start-page: 2024 issue: 10 year: 2014 end-page: 32 ident: CR111 article-title: TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations publication-title: Br J Cancer doi: 10.1038/bjc.2014.538 contributor: fullname: Mangesius – volume: 16 start-page: 3368 issue: 13 year: 2010 end-page: 77 ident: CR119 article-title: A distinct spectrum of copy number aberrations in pediatric high-grade gliomas publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-10-0438 contributor: fullname: Tamber – volume: 37 start-page: 1 issue: 5 year: 2015 end-page: 5 ident: CR11 article-title: Meta-analysis of the effect of isocitrate dehydrogenase 1 and 2 mutation on glioblastoma prognosis publication-title: Contemp Neurosurg doi: 10.1097/01.CNE.0000466892.11952.6f contributor: fullname: Jensen – volume: 462 start-page: 739 issue: 7274 year: 2009 end-page: 44 ident: CR23 article-title: Cancer-associated IDH1 mutations produce 2-hydroxyglutarate publication-title: Nature doi: 10.1038/nature08617 contributor: fullname: Driggers – volume: 1134 start-page: 45 issue: 1 year: 2007 end-page: 52 ident: CR107 article-title: Telomerase subunits expression variation between biopsy samples and cell lines derived from malignant glioma publication-title: Brain Res doi: 10.1016/j.brainres.2006.11.093 contributor: fullname: Roberts – volume: 16 start-page: 318 issue: 2 year: 2014 end-page: 9 ident: CR84 article-title: BRAF-V600E mutation in pediatric and adult glioblastoma publication-title: Neuro Oncol doi: 10.1093/neuonc/not146 contributor: fullname: Perry – volume: 71 start-page: 1319 issue: 10 year: 2014 end-page: 25 ident: CR17 article-title: IDH mutation in glioma: new insights and promises for the future publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2014.1205 contributor: fullname: Das – ident: CR114 – volume: 33 start-page: 1015 issue: 9 year: 2015 end-page: 22 ident: CR91 article-title: BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma publication-title: J Clin Oncol doi: 10.1200/JCO.2014.58.3922 contributor: fullname: Shago – volume: 107 start-page: 14075 issue: 32 year: 2010 end-page: 80 ident: CR75 article-title: Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1008850107 contributor: fullname: Allis – volume: 44 start-page: 770 issue: 5 year: 2012 end-page: 5 ident: CR34 article-title: Glioma derived isocitrate dehydrogenase-2 mutations induced up-regulation of HIF-1alpha and beta-catenin signaling: possible impact on glioma cell metastasis and chemo-resistance publication-title: Int J Biochem Cell Biol doi: 10.1016/j.biocel.2012.01.017 contributor: fullname: Liang – volume: 340 start-page: 622 issue: 6132 year: 2013 end-page: 6 ident: CR60 article-title: Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation publication-title: Science doi: 10.1126/science.1234769 contributor: fullname: Hansen – volume: 35 start-page: 2818 issue: 16 year: 2015 end-page: 30 ident: CR78 article-title: Genetic inactivation of ATRX leads to a decrease in the amount of telomeric cohesin and level of telomere transcription in human glioma cells publication-title: Mol Cell Biol doi: 10.1128/MCB.01317-14 contributor: fullname: Grandin – volume: 483 start-page: 474 issue: 7390 year: 2012 end-page: 8 ident: CR29 article-title: IDH mutation impairs histone demethylation and results in a block to cell differentiation publication-title: Nature doi: 10.1038/nature10860 contributor: fullname: Abdel-Wahab – volume: 12 start-page: 356 year: 2014 ident: CR98 article-title: Response of recurrent BRAFV600E mutated ganglioglioma to vemurafenib as single agent publication-title: J Transl Med doi: 10.1186/s12967-014-0356-1 contributor: fullname: Giangaspero – volume: 16 start-page: 81 issue: 1 year: 2014 end-page: 91 ident: CR53 article-title: IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection publication-title: Neuro Oncol doi: 10.1093/neuonc/not159 contributor: fullname: Cabral – volume: 118 start-page: 1739 issue: 5 year: 2008 end-page: 49 ident: CR89 article-title: BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas publication-title: J Clin Invest doi: 10.1172/JCI33656 contributor: fullname: Becker – volume: 21 start-page: 373 issue: 117 year: 2016 end-page: 80 ident: CR54 article-title: Targeting isocitrate dehydrogenase (IDH) in cancer publication-title: Discov Med contributor: fullname: Janku – volume: 129 start-page: 133 issue: 1 year: 2015 end-page: 46 ident: CR82 article-title: ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma publication-title: Acta Neuropathol doi: 10.1007/s00401-014-1370-3 contributor: fullname: Koelsche – volume: 16 start-page: 9 year: 2015 ident: CR125 article-title: Quantification of cell identity from single-cell gene expression profiles publication-title: Genome Biol doi: 10.1186/s13059-015-0580-x contributor: fullname: Birnbaum – volume: 114 start-page: 237 issue: 2 year: 2013 end-page: 40 ident: CR97 article-title: Salvage therapy with BRAF inhibitors for recurrent pleomorphic xanthoastrocytoma: a retrospective case series publication-title: J Neurooncol doi: 10.1007/s11060-013-1176-5 contributor: fullname: Chamberlain – volume: 32 start-page: 1185 issue: 11 year: 2002 end-page: 96 ident: CR25 article-title: Cytosolic NADP(+)-dependent isocitrate dehydrogenase status modulates oxidative damage to cells publication-title: Free Radic Biol Med doi: 10.1016/S0891-5849(02)00815-8 contributor: fullname: Park – volume: 3 start-page: 850 issue: 10 year: 2012 end-page: 5 ident: CR55 article-title: Discovery of the first potent inhibitors of mutant IDH1 that lower tumor 2-HG in vivo publication-title: ACS Med Chem Lett doi: 10.1021/ml300225h contributor: fullname: Zhao – volume: 74 start-page: 1886 issue: 23 year: 2010 end-page: 90 ident: CR42 article-title: All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2 publication-title: Neurology doi: 10.1212/WNL.0b013e3181e1cf3a contributor: fullname: Falet – volume: 321 start-page: 1807 issue: 5897 year: 2008 end-page: 12 ident: CR7 article-title: An integrated genomic analysis of human glioblastoma multiforme publication-title: Science doi: 10.1126/science.1164382 contributor: fullname: Angenendt – volume: 132 start-page: 625 issue: 4 year: 2016 end-page: 34 ident: CR45 article-title: Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort publication-title: Acta Neuropathol doi: 10.1007/s00401-016-1611-8 contributor: fullname: Idbaih – volume: 3 start-page: 34 year: 2015 ident: CR37 article-title: DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status publication-title: Acta Neuropathol Commun doi: 10.1186/s40478-015-0213-3 contributor: fullname: Heathcock – volume: 46 start-page: 444 issue: 5 year: 2014 end-page: 50 ident: CR68 article-title: The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma publication-title: Nat Genet doi: 10.1038/ng.2938 contributor: fullname: Li – volume: 69 start-page: 260 issue: 2 year: 2016 end-page: 7 ident: CR72 article-title: Utility of ATRX immunohistochemistry in diagnosis of adult diffuse gliomas publication-title: Histopathology doi: 10.1111/his.12927 contributor: fullname: Saito – volume: 17 start-page: 510 issue: 5 year: 2010 end-page: 22 ident: CR32 article-title: Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma publication-title: Cancer Cell doi: 10.1016/j.ccr.2010.03.017 contributor: fullname: Berman – volume: 3 start-page: 1194 issue: 10 year: 2012 end-page: 203 ident: CR70 article-title: Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma publication-title: Oncotarget doi: 10.18632/oncotarget.689 contributor: fullname: Kastenhuber – volume: 20 start-page: 2898 issue: 11 year: 2014 end-page: 909 ident: CR43 article-title: Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-13-3052 contributor: fullname: Tateishi – volume: 112 start-page: 851 issue: 3 year: 2015 end-page: 6 ident: CR126 article-title: Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1320611111 contributor: fullname: Kushida – volume: 69 start-page: 9157 issue: 24 year: 2009 end-page: 9 ident: CR26 article-title: Mutant metabolic enzymes are at the origin of gliomas publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-09-2650 contributor: fullname: Parsons – volume: 372 start-page: 2499 issue: 26 year: 2015 end-page: 508 ident: CR6 article-title: Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors publication-title: N Engl J Med doi: 10.1056/NEJMoa1407279 contributor: fullname: Sicotte – volume: 14 start-page: PL04-5-PL-5 issue: 12 Supplement 2 year: 2015 ident: CR58 article-title: Abstract PL04-05: the first reported results of AG-120, a first-in-class, potent inhibitor of the IDH1 mutant protein, in a phase I study of patients with advanced IDH1-mutant solid tumors, including gliomas publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.TARG-15-PL04-05 contributor: fullname: Touat – volume: 482 start-page: 226 issue: 7384 year: 2012 end-page: 31 ident: CR67 article-title: Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma publication-title: Nature doi: 10.1038/nature10833 contributor: fullname: Jacob – volume: 32 start-page: 783 issue: 8 year: 2014 end-page: 90 ident: CR47 article-title: Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH publication-title: J Clin Oncol doi: 10.1200/JCO.2013.49.3726 contributor: fullname: Brachman – volume: 110 start-page: 5957 issue: 15 year: 2013 end-page: 62 ident: CR104 article-title: Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1219232110 contributor: fullname: Choudhari – volume: 20 start-page: 1394 issue: 12 year: 2014 end-page: 6 ident: CR122 article-title: Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma publication-title: Nat Med doi: 10.1038/nm.3716 contributor: fullname: Chen – volume: 31 start-page: 344 issue: 3 year: 2013 end-page: 50 ident: CR48 article-title: Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951 publication-title: J Clin Oncol doi: 10.1200/JCO.2012.43.2229 contributor: fullname: Delattre – volume: 21 start-page: 555 issue: 6 year: 2015 end-page: 9 ident: CR121 article-title: Functionally defined therapeutic targets in diffuse intrinsic pontine glioma publication-title: Nat Med doi: 10.1038/nm.3855 contributor: fullname: Debily – volume: 107 start-page: 197 issue: 1 year: 2012 end-page: 205 ident: CR51 article-title: Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy publication-title: J Neurooncol doi: 10.1007/s11060-011-0737-8 contributor: fullname: Bittinger – volume: 4 start-page: 116ra5 issue: 116 year: 2012 ident: CR49 article-title: Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas publication-title: Sci Transl Med doi: 10.1126/scitranslmed.3002796 contributor: fullname: Srinivasan – volume: 18 start-page: 553 issue: 6 year: 2010 end-page: 67 ident: CR27 article-title: Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation publication-title: Cancer Cell doi: 10.1016/j.ccr.2010.11.015 contributor: fullname: Shih – volume: 116 start-page: 597 issue: 6 year: 2008 end-page: 602 ident: CR12 article-title: Analysis of the IDH1 codon 132 mutation in brain tumors publication-title: Acta Neuropathol doi: 10.1007/s00401-008-0455-2 contributor: fullname: von Deimling – volume: 330 start-page: 336 issue: 6002 year: 2010 ident: CR22 article-title: IDH2 mutations in patients with D-2-hydroxyglutaric aciduria publication-title: Science doi: 10.1126/science.1192632 contributor: fullname: van der Knaap – volume: 110 start-page: 6021 issue: 15 year: 2013 end-page: 6 ident: CR106 article-title: TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1303607110 contributor: fullname: Diaz – volume: 23 start-page: 471 issue: 3 year: 2012 end-page: 80 ident: CR16 article-title: IDH mutations in human glioma publication-title: Neurosurg Clin N Am doi: 10.1016/j.nec.2012.04.009 contributor: fullname: Liau – volume: 7 start-page: 16384 issue: 13 year: 2016 end-page: 95 ident: CR74 article-title: Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas publication-title: Oncotarget contributor: fullname: Li – volume: 14 start-page: 258 year: 2014 ident: CR100 article-title: Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy publication-title: BMC Cancer doi: 10.1186/1471-2407-14-258 contributor: fullname: Gajjar – volume: 63 start-page: 541 issue: 3 year: 2016 end-page: 3 ident: CR95 article-title: Successful retreatment of a child with a refractory brainstem ganglioglioma with vemurafenib publication-title: Pediatr Blood Cancer doi: 10.1002/pbc.25787 contributor: fullname: Hayes – volume: 333 start-page: 425 issue: 6041 year: 2011 ident: CR66 article-title: Altered telomeres in tumors with ATRX and DAXX mutations publication-title: Science doi: 10.1126/science.1207313 contributor: fullname: Shi – volume: 111 start-page: 359 issue: 3 year: 2015 end-page: 64 ident: CR86 article-title: BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas publication-title: J Surg Oncol doi: 10.1002/jso.23822 contributor: fullname: Suh – volume: 344 start-page: 1396 issue: 6190 year: 2014 end-page: 401 ident: CR124 article-title: Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma publication-title: Science doi: 10.1126/science.1254257 contributor: fullname: Wakimoto – volume: 119 start-page: 487 issue: 4 year: 2010 end-page: 94 ident: CR18 article-title: The prognostic IDH1( R132) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma publication-title: Acta Neuropathol doi: 10.1007/s00401-010-0645-6 contributor: fullname: Bosch – volume: 343 start-page: 189 issue: 6167 year: 2014 end-page: 93 ident: CR9 article-title: Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma publication-title: Science doi: 10.1126/science.1239947 contributor: fullname: McLean – volume: 22 start-page: 2339 issue: 12 year: 2012 end-page: 55 ident: CR21 article-title: A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation publication-title: Genome Res doi: 10.1101/gr.132738.111 contributor: fullname: Powell – volume: 122 start-page: 2877 issue: 16 year: 2013 end-page: 87 ident: CR56 article-title: Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML publication-title: Blood doi: 10.1182/blood-2013-03-491571 contributor: fullname: Gorlich – volume: 67 start-page: 878 issue: 9 year: 2008 end-page: 87 ident: CR87 article-title: Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma publication-title: J Neuropathol Exp Neurol doi: 10.1097/NEN.0b013e3181845622 contributor: fullname: Eberhart – volume: 79 start-page: 1381 issue: 7 year: 1997 end-page: 93 ident: CR2 article-title: Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas publication-title: Cancer doi: 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W contributor: fullname: Pearl – volume: 22 start-page: 94 issue: 2 year: 2015 end-page: 101 ident: CR73 article-title: The evolving molecular genetics of low-grade glioma publication-title: Adv Anat Pathol doi: 10.1097/PAP.0000000000000049 contributor: fullname: Huse – volume: 529 start-page: 110 issue: 7584 year: 2016 end-page: 4 ident: CR38 article-title: Insulator dysfunction and oncogene activation in IDH mutant gliomas publication-title: Nature doi: 10.1038/nature16490 contributor: fullname: Stemmer-Rachamimov – ident: CR59 – volume: 31 start-page: e233 issue: 14 year: 2013 end-page: 6 ident: CR83 article-title: BRAF V600E mutation identifies a subset of low-grade diffusely infiltrating gliomas in adults publication-title: J Clin Oncol doi: 10.1200/JCO.2012.46.0220 contributor: fullname: Ellisen – volume: 50 start-page: 4804 issue: 21 year: 2011 end-page: 12 ident: CR24 article-title: A tale of two subunits: how the neomorphic R132H IDH1 mutation enhances production of alphaHG publication-title: Biochemistry doi: 10.1021/bi200499m contributor: fullname: Boyer – ident: CR62 – volume: 19 start-page: 764 issue: 4 year: 2013 end-page: 72 ident: CR3 article-title: The definition of primary and secondary glioblastoma publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-12-3002 contributor: fullname: Kleihues – volume: 46 start-page: 462 issue: 5 year: 2014 end-page: 6 ident: CR117 article-title: Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma publication-title: Nat Genet doi: 10.1038/ng.2950 contributor: fullname: Fiset – volume: 131 start-page: 803 issue: 6 year: 2016 end-page: 20 ident: CR1 article-title: The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary publication-title: Acta Neuropathol doi: 10.1007/s00401-016-1545-1 contributor: fullname: Cavenee – volume: 29 start-page: 335 issue: 3 year: 2010 end-page: 44 ident: CR92 article-title: Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation publication-title: Oncogene doi: 10.1038/onc.2009.333 contributor: fullname: Holmen – volume: 22 start-page: 1632 issue: 7 year: 2016 end-page: 41 ident: CR52 article-title: Treatment response assessment in IDH-mutant glioma patients by noninvasive 3D functional spectroscopic mapping of 2-hydroxyglutarate publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-15-0656 contributor: fullname: Iafrate – volume: 224 start-page: 334 issue: 3 year: 2011 end-page: 43 ident: CR39 article-title: IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours publication-title: J Pathol doi: 10.1002/path.2913 contributor: fullname: Berisha – volume: 21 start-page: 373 issue: 117 year: 2016 ident: 722_CR54 publication-title: Discov Med contributor: fullname: T Fujii – volume: 174 start-page: 1149 issue: 4 year: 2009 ident: 722_CR19 publication-title: Am J Pathol doi: 10.2353/ajpath.2009.080958 contributor: fullname: T Watanabe – volume: 122 start-page: 2877 issue: 16 year: 2013 ident: 722_CR56 publication-title: Blood doi: 10.1182/blood-2013-03-491571 contributor: fullname: A Chaturvedi – volume: 483 start-page: 479 issue: 7390 year: 2012 ident: 722_CR33 publication-title: Nature doi: 10.1038/nature10866 contributor: fullname: S Turcan – volume: 103 start-page: 143 issue: 2 year: 2011 ident: 722_CR30 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djq497 contributor: fullname: BC Christensen – volume: 71 start-page: 1319 issue: 10 year: 2014 ident: 722_CR17 publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2014.1205 contributor: fullname: Z Turkalp – volume: 74 start-page: 1886 issue: 23 year: 2010 ident: 722_CR42 publication-title: Neurology doi: 10.1212/WNL.0b013e3181e1cf3a contributor: fullname: M Labussiere – volume: 46 start-page: 462 issue: 5 year: 2014 ident: 722_CR117 publication-title: Nat Genet doi: 10.1038/ng.2950 contributor: fullname: AM Fontebasso – ident: 722_CR62 doi: 10.1182/blood.V124.21.115.115 – volume: 38 start-page: E2 issue: 3 year: 2015 ident: 722_CR44 publication-title: Neurosurg Focus doi: 10.3171/2015.1.FOCUS14745 contributor: fullname: R Chen – volume: 116 start-page: 597 issue: 6 year: 2008 ident: 722_CR12 publication-title: Acta Neuropathol doi: 10.1007/s00401-008-0455-2 contributor: fullname: J Balss – volume: 32 start-page: 783 issue: 8 year: 2014 ident: 722_CR47 publication-title: J Clin Oncol doi: 10.1200/JCO.2013.49.3726 contributor: fullname: JG Cairncross – volume: 46 start-page: 457 issue: 5 year: 2014 ident: 722_CR120 publication-title: Nat Genet doi: 10.1038/ng.2925 contributor: fullname: KR Taylor – volume: 1134 start-page: 45 issue: 1 year: 2007 ident: 722_CR107 publication-title: Brain Res doi: 10.1016/j.brainres.2006.11.093 contributor: fullname: A Shervington – volume: 22 start-page: 425 issue: 4 year: 2012 ident: 722_CR116 publication-title: Cancer Cell doi: 10.1016/j.ccr.2012.08.024 contributor: fullname: D Sturm – volume: 107 start-page: 197 issue: 1 year: 2012 ident: 722_CR51 publication-title: J Neurooncol doi: 10.1007/s11060-011-0737-8 contributor: fullname: WB Pope – volume: 111 start-page: 2024 issue: 10 year: 2014 ident: 722_CR111 publication-title: Br J Cancer doi: 10.1038/bjc.2014.538 contributor: fullname: M Labussiere – volume: 22 start-page: 1632 issue: 7 year: 2016 ident: 722_CR52 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-15-0656 contributor: fullname: OC Andronesi – volume: 29 start-page: 335 issue: 3 year: 2010 ident: 722_CR92 publication-title: Oncogene doi: 10.1038/onc.2009.333 contributor: fullname: JP Robinson – volume: 340 start-page: 857 issue: 6134 year: 2013 ident: 722_CR118 publication-title: Science doi: 10.1126/science.1232245 contributor: fullname: PW Lewis – volume: 164 start-page: 550 issue: 3 year: 2016 ident: 722_CR5 publication-title: Cell doi: 10.1016/j.cell.2015.12.028 contributor: fullname: M Ceccarelli – volume: 16 start-page: 9 year: 2015 ident: 722_CR125 publication-title: Genome Biol doi: 10.1186/s13059-015-0580-x contributor: fullname: I Efroni – volume: 6 start-page: 18105 issue: 20 year: 2015 ident: 722_CR80 publication-title: Oncotarget doi: 10.18632/oncotarget.3906 contributor: fullname: J Cai – volume: 46 start-page: 444 issue: 5 year: 2014 ident: 722_CR68 publication-title: Nat Genet doi: 10.1038/ng.2938 contributor: fullname: G Wu – volume: 121 start-page: 397 issue: 3 year: 2011 ident: 722_CR85 publication-title: Acta Neuropathol doi: 10.1007/s00401-011-0802-6 contributor: fullname: G Schindler – volume: 343 start-page: 189 issue: 6167 year: 2014 ident: 722_CR9 publication-title: Science doi: 10.1126/science.1239947 contributor: fullname: BE Johnson – volume: 360 start-page: 765 issue: 8 year: 2009 ident: 722_CR10 publication-title: N Engl J Med doi: 10.1056/NEJMoa0808710 contributor: fullname: H Yan – volume: 3 start-page: 1194 issue: 10 year: 2012 ident: 722_CR70 publication-title: Oncotarget doi: 10.18632/oncotarget.689 contributor: fullname: K Kannan – volume: 114 start-page: 237 issue: 2 year: 2013 ident: 722_CR97 publication-title: J Neurooncol doi: 10.1007/s11060-013-1176-5 contributor: fullname: MC Chamberlain – volume: 22 start-page: 2339 issue: 12 year: 2012 ident: 722_CR21 publication-title: Genome Res doi: 10.1101/gr.132738.111 contributor: fullname: CG Duncan – volume: 12 start-page: 356 year: 2014 ident: 722_CR98 publication-title: J Transl Med doi: 10.1186/s12967-014-0356-1 contributor: fullname: F Bufalo del – volume: 111 start-page: 359 issue: 3 year: 2015 ident: 722_CR86 publication-title: J Surg Oncol doi: 10.1002/jso.23822 contributor: fullname: D Lee – volume: 372 start-page: 2481 issue: 26 year: 2015 ident: 722_CR4 publication-title: N Engl J Med doi: 10.1056/NEJMoa1402121 contributor: fullname: DJ Brat – volume: 38 start-page: E4 issue: 3 year: 2015 ident: 722_CR41 publication-title: Neurosurg Focus doi: 10.3171/2015.1.FOCUS14755 contributor: fullname: M Karsy – volume: 112 start-page: 851 issue: 3 year: 2015 ident: 722_CR126 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1320611111 contributor: fullname: M Meyer – volume: 69 start-page: 9157 issue: 24 year: 2009 ident: 722_CR26 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-09-2650 contributor: fullname: H Yan – volume: 79 start-page: 1381 issue: 7 year: 1997 ident: 722_CR2 publication-title: Cancer doi: 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W contributor: fullname: SW Coons – volume: 529 start-page: 110 issue: 7584 year: 2016 ident: 722_CR38 publication-title: Nature doi: 10.1038/nature16490 contributor: fullname: WA Flavahan – volume: 129 start-page: 133 issue: 1 year: 2015 ident: 722_CR82 publication-title: Acta Neuropathol doi: 10.1007/s00401-014-1370-3 contributor: fullname: DE Reuss – volume: 37 start-page: 685 issue: 5 year: 2013 ident: 722_CR90 publication-title: Am J Surg Pathol doi: 10.1097/PAS.0b013e31827f9c5e contributor: fullname: BK Kleinschmidt-DeMasters – volume: 44 start-page: 251 issue: 3 year: 2012 ident: 722_CR115 publication-title: Nat Genet doi: 10.1038/ng.1102 contributor: fullname: G Wu – volume: 118 start-page: 469 issue: 4 year: 2009 ident: 722_CR14 publication-title: Acta Neuropathol doi: 10.1007/s00401-009-0561-9 contributor: fullname: C Hartmann – volume: 3 start-page: 4 year: 2015 ident: 722_CR64 publication-title: Acta Neuropathol Commun doi: 10.1186/s40478-014-0180-0 contributor: fullname: S Pellegatta – ident: 722_CR59 doi: 10.1016/S0959-8049(14)70722-1 – volume: 2 start-page: e1501354 issue: 3 year: 2016 ident: 722_CR113 publication-title: Sci Adv doi: 10.1126/sciadv.1501354 contributor: fullname: RR Lulla – volume: 16 start-page: 318 issue: 2 year: 2014 ident: 722_CR84 publication-title: Neuro Oncol doi: 10.1093/neuonc/not146 contributor: fullname: S Dahiya – volume: 20 start-page: 2898 issue: 11 year: 2014 ident: 722_CR43 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-13-3052 contributor: fullname: H Wakimoto – volume: 43 start-page: 1256 issue: 12 year: 2011 ident: 722_CR40 publication-title: Nat Genet doi: 10.1038/ng.1004 contributor: fullname: TC Pansuriya – volume: 333 start-page: 425 issue: 6041 year: 2011 ident: 722_CR66 publication-title: Science doi: 10.1126/science.1207313 contributor: fullname: CM Heaphy – volume: 31 start-page: 344 issue: 3 year: 2013 ident: 722_CR48 publication-title: J Clin Oncol doi: 10.1200/JCO.2012.43.2229 contributor: fullname: MJ Bent van den – volume: 125 start-page: 353 issue: 2 year: 2009 ident: 722_CR15 publication-title: Int J Cancer doi: 10.1002/ijc.24379 contributor: fullname: MR Kang – volume: 113 start-page: 277 issue: 2 year: 2013 ident: 722_CR46 publication-title: J Neurooncol doi: 10.1007/s11060-013-1107-5 contributor: fullname: H Sun – volume: 14 start-page: 258 year: 2014 ident: 722_CR100 publication-title: BMC Cancer doi: 10.1186/1471-2407-14-258 contributor: fullname: GW Robinson – volume: 63 start-page: 541 issue: 3 year: 2016 ident: 722_CR95 publication-title: Pediatr Blood Cancer doi: 10.1002/pbc.25787 contributor: fullname: D Aguilera – volume: 37 start-page: 1 issue: 5 year: 2015 ident: 722_CR11 publication-title: Contemp Neurosurg doi: 10.1097/01.cne.0000466893.11952.26 contributor: fullname: M Karsy – volume: 482 start-page: 226 issue: 7384 year: 2012 ident: 722_CR67 publication-title: Nature doi: 10.1038/nature10833 contributor: fullname: J Schwartzentruber – volume: 31 start-page: e233 issue: 14 year: 2013 ident: 722_CR83 publication-title: J Clin Oncol doi: 10.1200/JCO.2012.46.0220 contributor: fullname: AS Chi – volume: 46 start-page: 731 issue: 7 year: 2014 ident: 722_CR108 publication-title: Nat Genet doi: 10.1038/ng.3004 contributor: fullname: KM Walsh – volume: 26 start-page: 57 year: 2016 ident: 722_CR110 publication-title: J Clin Neurosci doi: 10.1016/j.jocn.2015.05.066 contributor: fullname: Y Yuan – volume: 10 start-page: e0133813 issue: 9 year: 2015 ident: 722_CR57 publication-title: PLoS One doi: 10.1371/journal.pone.0133813 contributor: fullname: L Li – volume: 16 start-page: 508 issue: 8 year: 2016 ident: 722_CR105 publication-title: Nat Rev Cancer doi: 10.1038/nrc.2016.55 contributor: fullname: GM Arndt – volume: 34 start-page: e87 issue: 10 year: 2016 ident: 722_CR99 publication-title: J Clin Oncol doi: 10.1200/JCO.2013.51.1766 contributor: fullname: EQ Lee – volume: 7 start-page: 16384 issue: 13 year: 2016 ident: 722_CR74 publication-title: Oncotarget doi: 10.18632/oncotarget.7650 contributor: fullname: J Cai – volume: 35 start-page: 2818 issue: 16 year: 2015 ident: 722_CR78 publication-title: Mol Cell Biol doi: 10.1128/MCB.01317-14 contributor: fullname: R Eid – volume: 17 start-page: 510 issue: 5 year: 2010 ident: 722_CR32 publication-title: Cancer Cell doi: 10.1016/j.ccr.2010.03.017 contributor: fullname: H Noushmehr – volume: 44 start-page: 770 issue: 5 year: 2012 ident: 722_CR34 publication-title: Int J Biochem Cell Biol doi: 10.1016/j.biocel.2012.01.017 contributor: fullname: Y Fu – volume: 6 start-page: 9 issue: 1-2 year: 2015 ident: 722_CR93 publication-title: Genes Cancer doi: 10.18632/genesandcancer.48 contributor: fullname: CH Shin – volume: 110 start-page: 5957 issue: 15 year: 2013 ident: 722_CR104 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1219232110 contributor: fullname: AJ Sievert – volume: 23 start-page: 471 issue: 3 year: 2012 ident: 722_CR16 publication-title: Neurosurg Clin N Am doi: 10.1016/j.nec.2012.04.009 contributor: fullname: W Kim – volume: 126 start-page: 443 issue: 3 year: 2013 ident: 722_CR81 publication-title: Acta Neuropathol doi: 10.1007/s00401-013-1156-z contributor: fullname: B Wiestler – volume: 21 start-page: 555 issue: 6 year: 2015 ident: 722_CR121 publication-title: Nat Med doi: 10.1038/nm.3855 contributor: fullname: CS Grasso – volume: 131 start-page: 803 issue: 6 year: 2016 ident: 722_CR1 publication-title: Acta Neuropathol doi: 10.1007/s00401-016-1545-1 contributor: fullname: DN Louis – volume: 30 start-page: 7 issue: 1 year: 2009 ident: 722_CR13 publication-title: Hum Mutat doi: 10.1002/humu.20937 contributor: fullname: FE Bleeker – volume: 124 start-page: 615 issue: 5 year: 2012 ident: 722_CR71 publication-title: Acta Neuropathol doi: 10.1007/s00401-012-1031-3 contributor: fullname: XY Liu – volume: 11 start-page: 497 year: 2016 ident: 722_CR112 publication-title: Annu Rev Pathol doi: 10.1146/annurev-pathol-012615-044208 contributor: fullname: MG Filbin – volume: 321 start-page: 1807 issue: 5897 year: 2008 ident: 722_CR7 publication-title: Science doi: 10.1126/science.1164382 contributor: fullname: DW Parsons – volume: 3 start-page: 34 year: 2015 ident: 722_CR37 publication-title: Acta Neuropathol Commun doi: 10.1186/s40478-015-0213-3 contributor: fullname: A Cohen – volume: 122 start-page: 240 issue: 21 year: 2013 ident: 722_CR61 publication-title: Blood doi: 10.1182/blood.V122.21.240.240 contributor: fullname: K Yen – volume: 179 start-page: 1608 issue: 4 year: 2011 ident: 722_CR77 publication-title: Am J Pathol doi: 10.1016/j.ajpath.2011.06.018 contributor: fullname: CM Heaphy – volume: 3 start-page: 709 issue: 7 year: 2012 ident: 722_CR69 publication-title: Oncotarget doi: 10.18632/oncotarget.588 contributor: fullname: Y Jiao – volume: 33 start-page: 1015 issue: 9 year: 2015 ident: 722_CR91 publication-title: J Clin Oncol doi: 10.1200/JCO.2014.58.3922 contributor: fullname: M Mistry – volume: 13 start-page: 84 issue: 1 year: 2011 ident: 722_CR31 publication-title: Neuro Oncol doi: 10.1093/neuonc/noq110 contributor: fullname: J Laffaire – volume: 67 start-page: 878 issue: 9 year: 2008 ident: 722_CR87 publication-title: J Neuropathol Exp Neurol doi: 10.1097/NEN.0b013e3181845622 contributor: fullname: EE Bar – volume: 50 start-page: 4804 issue: 21 year: 2011 ident: 722_CR24 publication-title: Biochemistry doi: 10.1021/bi200499m contributor: fullname: B Pietrak – volume: 512 start-page: 324 issue: 7514 year: 2014 ident: 722_CR65 publication-title: Nature doi: 10.1038/nature13387 contributor: fullname: T Schumacher – volume: 19 start-page: 764 issue: 4 year: 2013 ident: 722_CR3 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-12-3002 contributor: fullname: H Ohgaki – volume: 224 start-page: 334 issue: 3 year: 2011 ident: 722_CR39 publication-title: J Pathol doi: 10.1002/path.2913 contributor: fullname: MF Amary – volume: 22 start-page: 94 issue: 2 year: 2015 ident: 722_CR73 publication-title: Adv Anat Pathol doi: 10.1097/PAP.0000000000000049 contributor: fullname: S Venneti – volume: 119 start-page: 487 issue: 4 year: 2010 ident: 722_CR18 publication-title: Acta Neuropathol doi: 10.1007/s00401-010-0645-6 contributor: fullname: FE Bleeker – volume: 105 start-page: 345 issue: 2 year: 2011 ident: 722_CR20 publication-title: J Neurooncol doi: 10.1007/s11060-011-0596-3 contributor: fullname: M Mellai – volume: 20 start-page: 1394 issue: 12 year: 2014 ident: 722_CR122 publication-title: Nat Med doi: 10.1038/nm.3716 contributor: fullname: R Hashizume – volume: 132 start-page: 625 issue: 4 year: 2016 ident: 722_CR45 publication-title: Acta Neuropathol doi: 10.1007/s00401-016-1611-8 contributor: fullname: E Tabouret – volume: 17 start-page: 3590 issue: 11 year: 2011 ident: 722_CR94 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-10-3349 contributor: fullname: EH Raabe – volume: 18 start-page: 553 issue: 6 year: 2010 ident: 722_CR27 publication-title: Cancer Cell doi: 10.1016/j.ccr.2010.11.015 contributor: fullname: ME Figueroa – volume: 19 start-page: 17 issue: 1 year: 2011 ident: 722_CR28 publication-title: Cancer Cell doi: 10.1016/j.ccr.2010.12.014 contributor: fullname: W Xu – volume: 340 start-page: 622 issue: 6132 year: 2013 ident: 722_CR60 publication-title: Science doi: 10.1126/science.1234769 contributor: fullname: F Wang – volume: 26 start-page: 1425 issue: 11 year: 2013 ident: 722_CR76 publication-title: Mod Pathol doi: 10.1038/modpathol.2013.90 contributor: fullname: M Abedalthagafi – volume: 61 start-page: 1101 issue: 6 year: 2014 ident: 722_CR96 publication-title: Pediatr Blood Cancer doi: 10.1002/pbc.24891 contributor: fullname: F Bautista – volume: 74 start-page: 960 issue: 10 year: 2015 ident: 722_CR102 publication-title: J Neuropathol Exp Neurol doi: 10.1097/NEN.0000000000000240 contributor: fullname: A Usubalieva – volume: 32 start-page: 1185 issue: 11 year: 2002 ident: 722_CR25 publication-title: Free Radic Biol Med doi: 10.1016/S0891-5849(02)00815-8 contributor: fullname: SM Lee – volume: 18 start-page: 624 issue: 4 year: 2012 ident: 722_CR50 publication-title: Nat Med doi: 10.1038/nm.2682 contributor: fullname: C Choi – ident: 722_CR114 doi: 10.1038/nrc3811 – volume: 462 start-page: 739 issue: 7274 year: 2009 ident: 722_CR23 publication-title: Nature doi: 10.1038/nature08617 contributor: fullname: L Dang – volume: 101 start-page: 722 issue: 4 year: 2009 ident: 722_CR88 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6605179 contributor: fullname: K Jacob – volume: 483 start-page: 484 issue: 7390 year: 2012 ident: 722_CR35 publication-title: Nature doi: 10.1038/nature10898 contributor: fullname: P Koivunen – volume: 118 start-page: 1739 issue: 5 year: 2008 ident: 722_CR89 publication-title: J Clin Invest doi: 10.1172/JCI33656 contributor: fullname: S Pfister – volume: 110 start-page: 6021 issue: 15 year: 2013 ident: 722_CR106 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1303607110 contributor: fullname: PJ Killela – volume: 16 start-page: 3368 issue: 13 year: 2010 ident: 722_CR119 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-10-0438 contributor: fullname: DA Bax – volume: 14 start-page: PL04-5-PL-5 issue: 12 Supplement 2 year: 2015 ident: 722_CR58 publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.targ-15-pl04-05 contributor: fullname: H Burris – volume: 31 start-page: e159 issue: 10 year: 2013 ident: 722_CR101 publication-title: J Clin Oncol doi: 10.1200/JCO.2012.44.1568 contributor: fullname: S Rush – volume: 347 start-page: 273 issue: 6219 year: 2015 ident: 722_CR79 publication-title: Science doi: 10.1126/science.1257216 contributor: fullname: RL Flynn – volume: 60 start-page: 110 issue: Suppl 1 year: 2013 ident: 722_CR103 publication-title: Neurosurgery doi: 10.1227/01.neu.0000430768.25844.4d contributor: fullname: SS Lang – volume: 372 start-page: 2499 issue: 26 year: 2015 ident: 722_CR6 publication-title: N Engl J Med doi: 10.1056/NEJMoa1407279 contributor: fullname: JE Eckel-Passow – volume: 3 start-page: 850 issue: 10 year: 2012 ident: 722_CR55 publication-title: ACS Med Chem Lett doi: 10.1021/ml300225h contributor: fullname: J Popovici-Muller – volume: 4 start-page: 116ra5 issue: 116 year: 2012 ident: 722_CR49 publication-title: Sci Transl Med doi: 10.1126/scitranslmed.3002796 contributor: fullname: A Elkhaled – volume: 483 start-page: 474 issue: 7390 year: 2012 ident: 722_CR29 publication-title: Nature doi: 10.1038/nature10860 contributor: fullname: C Lu – volume: 488 start-page: 404 issue: 7411 year: 2012 ident: 722_CR123 publication-title: Nature doi: 10.1038/nature11262 contributor: fullname: L Kruidenier – ident: 722_CR109 doi: 10.1007/s12035-016-9930-2 – volume: 330 start-page: 336 issue: 6002 year: 2010 ident: 722_CR22 publication-title: Science doi: 10.1126/science.1192632 contributor: fullname: M Kranendijk – volume: 107 start-page: 14075 issue: 32 year: 2010 ident: 722_CR75 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1008850107 contributor: fullname: PW Lewis – volume: 340 start-page: 626 issue: 6132 year: 2013 ident: 722_CR63 publication-title: Science doi: 10.1126/science.1236062 contributor: fullname: D Rohle – volume: 69 start-page: 260 issue: 2 year: 2016 ident: 722_CR72 publication-title: Histopathology doi: 10.1111/his.12927 contributor: fullname: M Ikemura – volume: 324 start-page: 261 issue: 5924 year: 2009 ident: 722_CR36 publication-title: Science doi: 10.1126/science.1170944 contributor: fullname: S Zhao – volume: 17 start-page: 98 issue: 1 year: 2010 ident: 722_CR8 publication-title: Cancer Cell doi: 10.1016/j.ccr.2009.12.020 contributor: fullname: RG Verhaak – volume: 16 start-page: 81 issue: 1 year: 2014 ident: 722_CR53 publication-title: Neuro Oncol doi: 10.1093/neuonc/not159 contributor: fullname: J Beiko – volume: 344 start-page: 1396 issue: 6190 year: 2014 ident: 722_CR124 publication-title: Science doi: 10.1126/science.1254257 contributor: fullname: AP Patel |
SSID | ssj0020079 |
Score | 2.4835653 |
SecondaryResourceType | review_article |
Snippet | Purpose of Review
This review will discuss the role of several key players in glioma classification and biology, namely isocitrate dehydrogenase 1 and 2... This review will discuss the role of several key players in glioma classification and biology, namely isocitrate dehydrogenase 1 and 2 (IDH1/2), alpha... Purpose of Review This review will discuss the role of several key players in glioma classification and biology, namely isocitrate dehydrogenase 1 and 2... PURPOSE OF REVIEWThis review will discuss the role of several key players in glioma classification and biology, namely isocitrate dehydrogenase 1 and 2... |
SourceID | proquest crossref pubmed springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 19 |
SubjectTerms | Brain Neoplasms - genetics DNA Helicases - genetics Genomics Glioma - classification Glioma - diagnosis Glioma - genetics Histones - genetics Humans Isocitrate Dehydrogenase - genetics Medicine Medicine & Public Health Mutation Neuro-Oncology (LE Abrey Neurology Neurosciences Nuclear Proteins - genetics Proto-Oncogene Proteins B-raf - genetics Section Editor Telomerase - genetics Topical Collection on Neuro-Oncology X-linked Nuclear Protein |
SummonAdditionalLinks | – databaseName: SpringerLINK - Czech Republic Consortium dbid: AGYKE link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3JTsMwEB1BkRAX9iVsMhInaKs2sYnDrSxtAZUDKlI5RXZsSwhIEbQXvp6ZLAVUOHCO5SQzXt7M8zwDHGppGtZRpKpOOAUophZxQXShUFLqyAWWCoV7tyfde349EIMZ8Cepi_SpXjKS2UL9VeuGkQWdoaLMGgVQszAnSO-rAnOtzsPN5STMwtZRppJKeSMckyWX-VsnP3ejKYg5RY9mu057Ka8EfM_ECumwyVN9PNL15GNayvEfP7QMiwUIZa181KzAjE1XYb5X0Oxr0MGlj_XKi3NZealnntxjCHNZ5_lx-KJO2dVFt8pa_btBlZ3dtdpVhui4X2XdgN34YW8d7tuX_fNurbhxoZbwQI5q6E8tE-0LSTBAO8SCgltfRQnhRodgzjS5TpwULmkYZ5R2zoZcGuWaiTU62IBKOkztFjCSygu18aOQiEuFSINLobUNDee-UtqDo9Ly8WsurBF_SSiTaWI0TUymiYUHu6Vv4mKOvcfYP8K3SDR8Dw4mj3F2EOWhUjsc520QsjSC0IPN3KeTt2GwSYW0gQfHpYO-df7Xp2z_q_UOLPiZh-n8yy5URm9ju4coZqT3i2H7CWTo4j8 priority: 102 providerName: Springer Nature |
Title | New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M |
URI | https://link.springer.com/article/10.1007/s11910-017-0722-5 https://www.ncbi.nlm.nih.gov/pubmed/28271343 https://www.proquest.com/docview/1875059502 https://search.proquest.com/docview/1875406037 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT9swED_RVkLwxNdYgFVG2hM0WuvYxNnLVEY_BiqaqlbqniI7tqVJ0AIt___u8lGYqu01iRLr7uL73f18dwCfjbJt5ylS1VeCAhQbJkISXSi1UibxkaNC4dH91XAqbmdyVibcluWxympPzDdqu8goR_6lg8AaoYBs829PzyFNjSJ2tRyhUYMG7wiiaRvXvfuf43XIhR4wyTumUg4J7bPiNfPiOQxV6FAWpeooIvvbM23AzQ2qNPdA_T3YpaoEVqTy92HLzQ9ge1QS44cwwM2KjapRt6waw1mk4xgCUzZ4-L141F_Zj5thi3Un41mLXY-7_RZDPDtpsWHE7ng8OoJpvzf5PgzLGQlhJiK1ClEDRmWGS0WO23hEb1I4rpOMkJ5H-GU7wmReSZ-1rbfaeO9ioaz2ncxZE32A-nwxdx-BUXO72FiexEQ1asQGQkljXGyF4FqbAC4q-aRPRSuM9K3pMQkzRWGmJMxUBnBWSTAt_4pl-qbDAM7Xt9GeiaTQc7d4LZ5BkNGO4gCOC8mvv4bhIZW-RgFcVqp49_J_LeXk_0s5hR2eGwEdUTmD-url1X1CoLEyTajFs7gJje7g112vWdoWXp3y7h-R9s0S |
link.rule.ids | 314,315,786,790,798,12083,21416,27953,27955,27956,31752,31753,33777,33778,41114,41556,42183,42625,43343,43838,52144,52267,74100,74657 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3JTsMwEB2xSCwndsJqJE7QiDaxG4cLYithCQdUpN4iO7YlJGiBlv9nJgsFITgnSqyXiefNPM8MwL6WpmkdRaqqzSlAMX7MBcmFQkmpYxdaKhRO79vJI7_piV6VcBtWxyrrPbHYqM0gpxz5UQuJNVIB0QxOXt98mhpF6mo1QmMSpnkYcrLzqDcOuND_xUW_VMogoXXWqmZROoeBCh3JokQdxWM__dIvsvlLKC38T2cB5qkmgZWJ_EWYsP0lmEkrWXwZrnCrYmk96JbVQzjLZBxDWsqunp8GL-qYXV8kDXbafeg12NnDaafBkM12GywJ2W0QpSvw2Lnsnid-NSHBz3koRz7ir2WuAyHJbWuH3E1wG6g4J57nkHyZFte5k8LlTeOM0s7ZiEujXCu3RoerMNUf9O06MGptF2kTxBEJjQqZAZdCaxsZzgOltAcHNT7Za9kIIxu3PCYwMwQzIzAz4cFWjWBW_RPDbPwFPdj7uozWTBKF6tvBR3kPUoxmGHmwViL_9TYMDqnwNfTgsP4U3x7-11I2_l_KLswm3fQuu7u-v92EuaAwCDqssgVTo_cPu42UY6R3Crv6BMY3yzU |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZT8MwDLY4pAmeuClnkHiCVXRtQlNe0DjGYAwhNKS9VUmTSEiwcYz_j91jAyF4btVGjhN_9ucDYF9LE1hHnqo65uSgGD_hguhCoaTUiYssFQp3747bj_ymL_pl_tNHmVZZ3Yn5RW2GGcXIjxoIrBEKiCA8cmVaxP1F6_T1zacJUsS0luM0pmEWrWRAYxzi_sT5QluY5L1TKZqEmloxnHkZHTotlJ5FQTvyzX7aqF_A8xdpmtui1gLMU30CK4L6izBlB0tQ65YU-TJc4bXFutXQW1YN5CwCcwwhKrt6fhq-qBN2fdGus2bvoV9nZw_NVp0hsu3VWTtinTDursBj67J33vbLaQl-xiM58nEvtMx0KCSZcO0QxwluQ5VkhPkcAjHT4DpzUrgsMM4o7ZyNuTTKNTJrdLQKM4PhwK4DozZ3sTZhEhPpqBAlcCm0trHhPFRKe3BQySd9LZpipJP2xyTMFIWZkjBT4cFWJcG0PB8f6WQ3PdgbP0bNJrpCDezws3gH4UYQxR6sFZIf_w0dRSqCjTw4rLbi28f_WsrG_0vZhRqqVHp7fdfZhLkw1wfKW9mCmdH7p91G9DHSO7lafQGM089h |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=New+Molecular+Considerations+for+Glioma%3A+IDH%2C+ATRX%2C+BRAF%2C+TERT%2C+H3+K27M&rft.jtitle=Current+Neurology+and+Neuroscience+Reports&rft.au=Karsy%2C+Michael&rft.au=Guan%2C+Jian&rft.au=Cohen%2C+Adam+L&rft.au=Jensen%2C+Randy+L&rft.date=2017-02-01&rft.pub=Springer+Nature+B.V&rft.issn=1528-4042&rft.eissn=1534-6293&rft.volume=17&rft.issue=2&rft.spage=1&rft_id=info:doi/10.1007%2Fs11910-017-0722-5&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=4319581741 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1528-4042&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1528-4042&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1528-4042&client=summon |